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Abstract 
Reactive Oxygen Species have long been known to cause cellular stress and damage. 
But recently, ROS have been implicated as signaling molecules. Tumor cells display 
an altered redox status. Our lab has recently shown that expression of a constitutively 
active form of Rac1 (RacV12) inhibits tumor cell death by apoptosis through 
intracellular production of superoxide anion (O2-) (Pervaiz et al. 2001, Oncogene). 
Another characteristic of transformed cells is a shift towards alkaline intracellular pH. 
NHE-1, one of the major pHi regulators, has been shown to be of particular 
importance in tumor cells. Current study was designed to study the effect of ROS on 
NHE1 regulation and the role it may play in modulating apoptosis. Our data shows 
that production of intracellular O2•- induces transcription of NHE-1 while increase in 
H2O2 inhibited it. Using Rac mutants, which have differential ability to produce O2•- 
in the cell, and drugs that affect the intracellular ROS levels, we were able to show 
that NHE1 gene is redox-responsive. Changes in NHE1 gene expression were 
translated into NHE1 protein expression. By over-expressing or silencing NHE-1 
gene we show that cell response to apoptotic triggers such as staurosporin and 
etoposide correlates with the amount of NHE-1 protein expression on the cell surface. 
Moreover, down-regulation of NHE-1 gene expression in tumor cell lines tested 
reverted their resistant phenotype. These results support a critical role for NHE-1 
expression in tumor cells’ response to anticancer therapy and provide a possible 
mechanism for Rac1-mediated survival in tumor cells. 
 
Pervaiz S., Cao J., Chao OSP, Chin YY. Clément M-V. Activation of the RacGTPase inhibits apoptosis 
in human tumor cells. Oncogene 20: 6263-6268, 2001. 
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I.1. Cell Death 
Cell number in a multi-cellular organism is constant but dynamic. Cells are constantly 
undergoing growth; dead cells are replaced by new ones. Cell death can occur either 
accidentally or in a pre-determined fashion. Accidental cell death takes place when 
cells are suddenly exposed to conditions which are incompatible with life, for 
example, sheer physical stress, chemical poisons, radiation, etc. A process of cell 
death called “Necrosis” ensues, which leads to disintegration of cellular organelles, 
cytoplasmic swelling and finally membrane rupturing. On the other hand, cells can 
also decide to die. This happens when a cell becomes functionally redundant or is no 
longer needed for the organism. This type of cell death is called “Apoptosis” and 
comprises of a complex but very well orchestrated chain of events. In physiological 
circumstances apoptosis is the favorable mode of death as it does not lead to a spillage 
of intracellular contents into the extra-cellular space, and no or little immune reaction 
(Steller H, 1995; Wyllie AH et al., 1980). Salient differences between Apoptosis and 
Necrosis are tabulated in Fig A. 
One of the hallmarks of tumor development and maintenance is defiance of tumor 
cells to execute death signals (Thompson CB, 1995). Thus, a combination of 
increased proliferation and lack of cell death leads to the development of cancer mass. 
Cell death could occur via different mechanisms depending upon various factors like 
initiating triggers, tissue and cell type involved and so on. 
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I.1.a. Types of Cell Death 
Apoptosis and necrosis have classically been defined as two entirely different types of 
cell death, starting from the factors that can induce cell death, the signaling pathways, 
death execution and the way body clears away dead cells (Zhaoyu J and Wafik SD, 
2005). Despite these differences, recent observations have suggested that there might 
be some overlapping between these two morphologically distinct types of cell death 
(Nicotera P and Melino G, 2004; Lockshin RA and Zakeri Z, 2004). 
In addition, programmed cell death can occur without the classic morphological 
features of apoptosis. Historically speaking differentiation between apoptosis and 
necrosis were based upon morphological features of the dying cells. With in depth 
studies into the biochemical events occurring during cell death, many different types 
of cell deaths have now been defined (Melino G et al, 2005; Kroemer G et al, 2005; 
Kondo Y et al, 2005). Few examples of these other forms of cell death include 
autophagy, paraptosis, anoikis, Wallerian degeneration and cornification. Except for 
necrosis, all other forms of cell death are believed to have genetic component 
(Kroemer G et al, 2005). The type of cell death a particular cell choses may vary 
according to the prevailing circumstances. 
 
I.1.b. Programmed Cell Death or Apoptosis 
Programmed Cell Death and its morphologic manifestation of Apoptosis is a distinct 
genetically controlled process. The execution of apoptosis is characterized by a chain 
of both morphological and biochemical events. These include mitochondrial 
depolarization, chromatin condensation, nuclear fragmentation, membrane blebbing, 
cell shrinkage and formation of membrane bound vesicles termed as apoptotic bodies 







 NECROSIS APOPTOSIS 
Genetic Program None Yes 
Cell Membrane Lysed Intact, PS Exposure 
Organelles Lysed Intact 
Mitochondria Ruptured Intact 
Nucleus - Chr. Cond., DNA Frag. 
Enzymes None Caspases 
Receptors - Death Receptors 
Regulators - Bcl family, IAP 
 
 
Fig. A. Major differences between Apoptotic and Necrotic types of Cell Death. 
 
PS, Phosphotidylserine; Chr. Cond., Chromatin Condensation; IAP, Inhibitory 
Apoptotic Protein. 
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other essential cellular functions. Some of the molecular components of apoptotic 
machinery have been conserved through evolution (Steller H, 1995). An intact death 
pathway is required for successful organogenesis in embryonic life and maintenance 
of normal tissue homeostasis in adult organisms. As opposed to necrosis, apoptosis 
minimizes the leakage of cell contents into extracellular space, which in turn results in 
a minimal inflammatory response and tissue damage. Apoptosis has been studied 
most extensively in the worm, C elegans. Genetic studies have identified 14 genes in 
C. elegans that affect programmed cell death (Steller H, 1995), homologues of some 
of these genes have been identified in mammals. For example, two of C. elegans’ 
genes, ced-9 and ced-3 (ced stands for cell death defective), are homologous to 
mammalian genes: the proto-oncogene bcl-2 and ice (interleukin-1-β-converting 
enzyme), respectively 
Deregulation of apoptosis can be very detrimental to the organism. Excessive cell 
death can lead to a number of diseases, for example, AIDS, neurodegenerative 
disorders and ischemic injury (Thompson CB, 1995). In contrast, impaired apoptosis 
is a significant factor in the etiology of diseases like cancer, autoimmune disorders 
and viral infections.   
 
I.1.c. Apoptotic Machinery 
Apoptosis is a complex phenomenon of morphological and biochemical processes. 
The field of apoptosis has witnessed an explosion of information over the past two 
decades. The C. elegans hermaphrodite undergoes a distinct programmed cell death 
pattern in which the same 131 cells out of 1090 cells die during the development of 
this worm (Brenner et al., 1974; Sulston et al., 1976). In more complex organisms, 
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like mammals the regulation of apoptosis and its mechanism is far more intricate and 
complex.  
Apoptotic cell death occurs in two phases: first a commitment to cell death, followed 
by an execution phase characterized by specific morphological changes in cell 
structure. Classically, Apoptosis can be initiated with or without the involvement of 
mitochodria. In cell-surface receptor induced apoptosis, activation of Fas or TNF 
receptor leads to the activation of initiator caspase 8, followed by the activation of 
downstream effector caspases (Fig B). In mitochondrial or intrinsic pathway, upon 
apoptotic triggers there is a release of mitochondrial contents, most notably 
cytochrome C, into the cytosol. This leads to the formation of a complex between 
cytochrome C, Apaf1 and pro-Caspase 9, known as “Apoptosome”. Bcl-2 and Bcl-xL 
block death by preventing the release of mitochondrial contents into cytosol. On the 
other hand, pro-apoptotic members of Bcl-2 family like Bad and Bax, play an 
important role in facilitating apoptosis (Fig C). 
Executioners of apoptosis include a cascade of proteases termed caspases. Currently 
11 human caspases has been identified. Initiator caspases including caspase-1, 2, 4, 5, 
9, 11 and 12 interact with upstream adapter molecules and once activated lead to 
downstream activation of executioner caspases (caspase-3, 6 and 7). A striking feature 
of these enzymes is their specificity of substrate cleavage after an Asp residue 
(Degterev A et al, 2003). Caspase activation leads to the cleavage/degradation of a 
number of cellular proteins like PARP, Lamin A. 
To make the picture more complex, other families of proteins have been identified 
recently which are involved in the regulation of apoptosis. IAPs (Inhibitor of 

























Fig. C. Mitochondial pathway of Apoptosis. 
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dual name of Smac/DIABLO has been identified which promotes caspase activation 
and inhibits xIAP (Douglas RG, 2000). In summary, apoptotic machinery consists of 
a host of proteins interacting with each other in a complex and intricate manner, one 
group of proteins favoring apoptosis and the other opposing it. Thus, the decision to 
die is a matter of balance amongst anti- and pro-apoptotic proteins. 
To our interest, numerous studies have demonstrated redox-regulated functional 
modifications of many of the proteins involved in apoptotic machinery (Dechao L et 
al. 2004; John JH, 2004; Irani K and Pascal JGC, 1998). 
 
I.2. Reactive Oxygen Species and Apoptosis 
Cells generate reactive oxygen species (ROS) during aerobic metabolism. Higher 
levels of ROS are detrimental to cell’s functions, thus each cell has an extensive 
antioxidant defense system to scavenge excessive amounts of ROS. The intracellular 
redox state is controlled by the thioredoxin and glutathione systems (Mates JM and 
Sanchez-Jimenez F, 1999). Mitochondria are the major source of ROS, where 
electrons carried by the electron transport chain may leak out of the pathway and react 
with oxygen to form superoxide (O2.-). Other sources of O2.- include enzymes such as 
NADPH oxidase (NOX), lipoxygenases, cyclooxygenases, xanthine oxidase, and 
cytochrome P450. Once O2.- is generated it is rapidly converted to hydrogen peroxide 
(H2O2) by superoxide dismutase. Hydrogen peroxide can then react with Fe2+ to form 
hydroxyl radicals via the Fenton reaction. 
 
I.2.a. Pro and Anti-Apoptotic functions of ROS 
Over the past decade or so there has been a paradigm shift in the understanding of 
ROS and the functions they can play in the cell. The intracellular concentration of 
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these reactive molecules is kept under tight regulation by cells’ anti-oxidant systems. 
The anti-oxidant defense mechanisms include scavenger enzymes superoxide 
dismutase (SOD), catalase and glutathione peroxidase (Halliwell B and Gutteridge 
JMC, 1999). Therefore, accumulation of ROS in the cell is a function of the overall 
production and the efficiency of the anti-oxidant defences which could be cell 
specific. Several reports have suggested that phorbol esters stimulate the production 
of O2.- not only in phagocytic cells but in other cultured cells as well (Bonser et al, 
1986; Fischer et al, 1986). This small amount of O2.- produced in non-phagocytic cells 
in response to mitogenic stimuli may play some physiological role in the signal 
transduction. Reactive oxygen species (ROS) and Reactive nitrogen species (RNS) 
can affect a wide variety of cellular functions (Droge W, 2001; John JH, 2004; Finkel 
T, 2003). There is a growing consensus that redox status of a cell plays a regulatory 
role on a wide range of cellular functions: gene transcription, cell proliferation, 
differentiation and adaptation on one end, and apoptosis and necrosis on the other end 
of the spectrum (see Fig. D). 
Whereas the role of ROS in inducing necrotic cell death is well established, the role of 
ROS in apoptosis is more controversial. However, there is increasing body of 
evidence to support the role of ROS in apoptosis. 
The activity of caspase proteases has been shown to be influenced by the redox status 
of these enzymes (Hampton MB et al, 1998). Apoptosis in neutrophils and their 
clearance by macrophages has also been shown to be ROS dependent (Fadeel B and 
Kagan VE, 2003) 
Fas receptor activation is a major trigger for apoptosis, and it has been shown that O2.- 



















Fig. D. Wide array of functions attributed to Reactive Oxygen Species (ROS). 
 
John J. Haddad (2004) 
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and Stamenkovic I, 1996). Mitochondria can play an important role in modulating 
apoptosis through generation of ROS. It has been postulated that reversal of 
mitochondrial F0F1-ATPase in the inner membrane would lead to an increased 
concentration of H2O2 in the cytosol which in turn, would lead to PARP activation 
and ATP depletion. This depletion in ATP levels could lead to increase acid load in 
the cell either by production of H+ or inhibition of H+ transporters (Gossmann DL et 
al, 2004). 
Interestingly, cell surface receptor and mitochondrial pathways cross talk with each 
other through Bid that is a pro-apoptotic member of Bcl-2 family. Pro- and anti-
apoptotic proteins of this group form heterodimers and block each other’s activity. 
Expression levels of these proteins can be controlled at multiple levels: transcription, 
heterodimer formation and ubiquitination. Anti-apoptotic Bcl-2 family proteins, when 
phosphorylated, fail to bind to each other. Thus, it has been suggested that the 
phosphorylation status of Bcl-2 family proteins might affect their ability to regulate 
apoptosis (Ruvolo PP et al, 2001). ROS have been shown to induce apoptosis by 
regulating the phosphorylation and ubiquitination of Bcl-2 family proteins (Dechao L 
et al, 2004).  
The tumor suppressor p53, nick named Guardian of the Genome, plays an important 
role in the regulation of cellular response to DNA damage. p53 has been shown to 
participate in sensing oxidative DNA damage and modulates BER (base excision 
repair) function in response to persistent ROS stress (Achanta G and Huang P, 2004). 
In a recent study, stress-induced p53 activation showed strong ROS sensitivity both in 
leukemic and normal lymphocytes. These observations identified mitochondrial 
activity and ROS levels, as a critical intracellular determinant of the p53 stress 
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sensitivity and suggest potential implications of this linkage in the mechanisms of 
chemoresistance of acute leukemia cells (Karawajew L et al, 2005). 
Thus, it can be concluded that ROS can modulate or alter the activity of a number of 
very important proteins involved in cell death. Process of apoptosis can be divided 
into three distinct phases: initiation, effector and degradation. ROS can be involved in 
all three of these phases.  
Reactive Nitrogen Species (RNS) have a more established role in modulation of cell 
death. Nitric oxide (NO) is an important bioregulatory molecule in the nervous, 
immune and cardiovascular systems. NO participates in the regulation of many 
cellular functions as well as in cytotoxic events. It possesses a controversial effect on 
cell viability by acting both as a protection against apoptotic stimuli or by inducing 
apoptosis when produced at elevated concentrations (Blaise GA et al, 2005). 
The role of ROS will be discussed in more detail as the work presented in this 
manuscript was undertaken to study the role of ROS in apoptosis. 
 
I.2.b. Rac1 and Superoxide anion production 
Rac1 is a ubiquitously expressed small GTP-binding protein, that functions 
downstream of oncogene Ras. p21ras (c-Ras) has many functions in the cell, including 
proliferation, differentiation, apoptosis and cytoskeletal organization. Mutations in a 
ras allele that make it constitutively active have been found in 30% of all human 
tumors, making it the most widely mutated human proto-oncogene. Multiple 
pathways exist downstream of Ras, including activation of Rac1. 
Activated Rac1 leads to the generation of ROS, including O2.- (Irani K and Pascal 
JGC, 1998). Activation of Rac is classically known to trigger clustering of an enzyme 
complex, NADPH oxidase (NOX) in phagocytic cells. Activation of NADPH in these 
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cells catalyses the generation of O2.- (also known as “respiratory burst”) which in turn 
kills the ingested bacteria. Until recently, the single example of ‘deliberate’ 
generation of ROS in mammalian cells was the NOX of phagocytes (Phox). This 
enzyme is inactive in resting neutrophils, but is activated by exposure to 
microorganisms or inflammatory mediators, resulting in the rhobust production of 
ROS. Although the exact structure and localization of NADPH-like enzyme system 
has not been identified in non-phagocytic cells, Mox1 (mitogenic oxidase 1) has been 
cloned and characterized as a homologue to neutrophil gp91phox, which participates 
in ROS production (Suh YA, 1999). In contrast to a robust production of ROS in 
phagocytic cells, lower levels of ROS produced in non-phagocytic cells appear to act 
as secondary messengers or signaling molecules. Recent data suggests ROS produced 
downstream of Rac might play a role in the regulation of growth, transformation and 
apoptosis (Finkel T et al, 1999; Irani K et al, 1997). Rac isoform 1 has been identified 
in many non-phagocytic cells and is responsible for production of intracellular O2.-, as 
opposed to isoform 2 that has been described in phagocytic cells. The expression of 
these enzymes in various tissues provides evidence that generation of ROS is a 
general feature of many and perhaps all cells. Many cell types express NOX enzymes, 
probably accounting for the diverse cellular ROS generation seen in many of the 
earlier studies. Examples of non-phagocytic cells where NOX enzymes or its 
components have been identified include osteoclasts, fibroblasts, glomerular 
mesangial cells, chondrocytes, endothelial cells and keratinocytes (Bunn and Poyton, 
1996; Suh YA, 1999). 
As described earlier, O2.- is the primary ROS generated by normal cellular 
metabolism, whereas H2O2 is a catalytically derived intermediate in the conversion of 
O2.-  to O2 (Fridovich I, 1976; Halliwell B and Gutteridge JMC, 1989). In phagocytic 
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cells, large scale production of Nitric Oxide (NO) by macrophages, or O2.- by 
neutrophils, provides the host with defense function against invading pathogens, while 
when produced in smaller amounts in non-phagocytic cells, these same reactive 
molecules instead of causing damage to the cell function as signaling molecules 
(Finkel T, 2001). 
 
I.2.c. Superoxide anion and inhibition of apoptosis 
Mammalian cells possess multiple sources of ROS generation; most evidence 
suggests that plasma-membrane associated oxidases may provide one source of ROS 
associated with resistance to apoptotic triggers. O2.- has been shown to contribute to 
the unchecked proliferation in Ras-transformed fibroblasts (Irani K and Pascal JGC, 
1998). Although the exact source of O2.- in non-phagocytic cells is still under 
investigation, Rac has been implicated as a major component of O2.--generating 
system, and presence of NOX enzymes in a variety of cells suggests a role for ROS in 
various cellular functions.  
In addition, plasma membrane of many cells has another ROS-generating enzyme 
utilizing NADH as an electron donor. Both of these flavin-containing oxidases are 
inhibited by diphenylene iodonium (DPI). Taken together, NADH and NADPH 
oxidases may provide candidate sources of O2.- production associated with cells’ 
resistance to apoptotic cell death. As described in the previous section, O2.- can block 
the Fas-induced cell death in tumor cells.  
The regulation of tumor cells’ sensitivity to death stimuli has been shown to be linked 
to the intracellular levels of O2.- and H2O2  (Pervaiz S and Clement MV, 2002 and 
2004; Clement MV and Pervaiz S, 1999 and 2001). Interestingly, an increase in 
intracellular O2.- concentration achieved by either its direct overproduction (Clement 
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MV and Stamenkovic I, 1996), drug-induced (Pervaiz S et al, 1999; Ahmad KA et al, 
2004), activation of the small GTPase Rac1 (Pervaiz S et al, 2001), or as a result of an 
inhibition of the O2.- scavenger Cu/Zn SOD (Pervaiz S et al, 1999), inhibits tumor cell 
apoptosis triggered by either the CD95 receptor or anticancer drugs. In contrast, H2O2 
is a widely accepted trigger of apoptotic cell death (Hirpara JL et al, 2001) and non-
toxic levels of H2O2 sensitize cells to death triggers (Clement MV et al., 1998). 
Earlier reports have highlighted the regulatory role of intracellular redox status on 
death signaling by demonstrating an effect on caspase family protease, the central 
executioners of apoptotic signals (Hampton M and Orrenius S, 1998; Chandra J et al, 
2000). 
 
I.3. Intracellular milieu 
Various mechanisms of how ROS can lead to cell transformation have been proposed. 
O2.- or other “oxidants” may induce targeted damage to chromosomal DNA, leading 
to enhanced rate of oncogenic mutations or they can directly regulate the signaling 
cascade that underlies malignant transformation (Irani K et al, 1997). ROS have been 
shown to activate NF-κB, a transcription factor whose activation has been linked to 
apoptosis. Evidence has grown in this poorly understood field and many signal-
transducing proteins and transcription factors have been added to the list of “redox-
sensitive” proteins (Sundaresan M et al, 1996).  
Apoptosis is a tightly regulated chain of reactions that involves many enzymatic 
reactions and proper functioning of all of its components is essential to execute a cell 
in a predetermined fashion. The executioners of apoptosis, especially caspases are 
very sensitive to redox alterations and require a reducing environment to be 



























Fig. E. A model of ROS-mediated regulation of Apoptosis. 
 
Figure adapted from Pervaiz S and Clement MV (2002a).  
Receptor (CD95/Fas)-induced apoptosis is mediated by early caspase 8 recruitment 
and activation, which can induce a drop in cytosolic pH (pHc) and facilitate the 
activation of downstream executioner caspases, such as caspase 3. Other stimuli, such 
as anticancer drugs and ultraviolet irradiation (UV) are dependent upon mitochondrial 
death factors for efficient execution. One scenario could be a direct stimulation of 
mitochondrial ROS production, which leads to H2O2-mediated membrane damage and 
escape of proapoptotic factors like cyt c. H2O2 can also diffuse out from the 
mitochondria and trigger cytosolic acidification, thereby creating a permissive 
environment for caspase activation. The inhibitory effect of O2- (NADPH oxidase- or 
mitochondria-derived) on the apoptotic pathway could be via blocking upstream or 
downstream caspase activation directly or by inhibiting cytosolic acidification. 
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function (Thornberry NA and Lazebnik Y, 1998). This thiol group renders them 
particularly susceptible to redox modification by oxidation. Such chemical 
modification results in loss of their catalytic activities. In addition treatment of cells 
with exogenous oxidizing agents triggers apoptosis in a variety of cell types 
(Hampton M and Orrenius S, 1998). 
Recent findings in our lab have led us to believe that the delicate balance of ROS 
production and elimination leads to an intracellular environment that may be 
favorable to apoptotic pathway on one end or it may be non-conducive on the other. 
To this end, the most interesting observations have been made with regards to a 
complex interplay between different ROS. Balance between the intracellular level of 
O2.- and H2O2 seems to play a critical role in determining whether a cell is ready to die 
or not (Clement MV and Pervaiz S, 2001). As discussed in the previous section, 
hydrogen peroxide at non-toxic conditions leads to apoptotic cell death. Surprisingly, 
this effect of H2O2 seems to be a function of reduced levels of O2.- anion in the cell 
(Clement MV et al, 1998). The mechanism of this relationship is not completely 
understood, and is currently a main focus of research in our lab. 
 
I.3.a. Intracellular pH (pHi) 
Interestingly, O2.- has been suggested to affect intracellular pH (pHi) (Shibanuma M 
et al, 1988). Recent data from our group also suggested that redox regulation of cell 
survival in tumor cells could be associated with regulation of intracellular pH (Pervaiz 
S and Clement MV, 2002a) (see Fig B). 
Tumors, although may arise from many different genetic alterations, lead to a loss of 
normal growth control mechanisms. Two phenotypes common to all tumor cells are 
cellular alkalinization and a shift towards glycolytic metabolism. Changes in 
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intracellular pH (pHi) can affect many cellular functions including metabolism, cell 
growth and cell mobility, and so on. Cell metabolism can be affected by pH-sensitive 
metabolic enzymes, such as phosphofructokinase. Changes in pHi have also been 
shown to affect polymerization of cytoskeletal elements like tubulin and actin. In 
tumor cells the pHi is more alkaline as compared to their normal counterparts.  
 
I.3.b. pHi and Apoptosis 
The relationship between pHi and extracellular pH (pHe) whitin a tumor have long 
been a highly controversial issue. However, in past few years it has been repeatedly 
shown that cancer cells have intracellular alkalinity (Harguindey S et al, 2005). A 
number of studies have highlighted the key role of increased pHi in tumor 
transformation, cell survival and metastatic potential of a tumor (Reshkin SJ et al, 
2000; DiGiammarino J et al, 2002; Pouyssegur J et al, 2001; Cardone RA et al, 2005) 
A direct cause and effect relationship among the degree of Multiple Drug Resistence 
(MDR) and the elevation of tumor pHi has been recognized by many different groups 
that have studied the dynamic interrelationships between cell pHi and MDR (Keizer 
HG and Joenje H, 1989; Weinsburg JH et al, 1999). 
Cells undergoing apoptosis show intracellular acidification. A wide range of apoptotic 
triggers lead to this intracellular acidification including UV irradiation, staurosporine, 
etoposide, anti-Fas antibodies and growth factor withdrawal (Matsuyama S et al, 
2000). 
Bcl-2 over-expression inhibits CD95 receptor-induced acidification in Jurkat cells 
(Petit F et al, 2001). A very interesting observation has been reported recently, where 
intracellular alkalinization has been proposed to induce tumorigenesis by 
destabilization of a mutant p53 tetramer (DiGiammarino J et al, 2002). Although 
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association between alkaline intracellular pH and tumorigenic transformation is well 
documented in scientific literature, there are conflicting reports concerning whether 
tumorigenic transformation follows intracellular alkalinization or vice versa. 
Interestingly, there is increasing evidence suggesting that alkalinization is an early 
key event for the establishment and maintenance of oncogenic transformation 
(Reshkin SJ et al, 2000; Gillies RJ et al, 1990).  
 
I.4. Intracellular pH regulation 
Normal functioning of cell metabolism occurs within a restricted intracellular pH 
(pHi) range. In most cells pHi is maintained at a value of about 7.0. Variations in 
ambient pH alter the occupancy of acidic and basic groups on various cellular proteins 
and other molecules. Thus, for the normal functioning of the cell, pHi has to be very 
tightly regulated. There are various mechanisms operating in a cell to regulate pH 
within this very narrow physiological range. Few important examples are H+ 
buffering by intracellular buffers, sequestering of H+ into intracellular compartments, 
CO2 diffusion across the cell membrane, carbonic anhydrase activity, and last but not 
the least transport of acid/base equivalents across cell membrane via specialized 
transporters. 
In fact many cells face a constant acid load due to metabolic acid production and 
leakage of H+ ions from intracellular compartments. Intracellular buffers can blunt 
this acid load but they will not be able to restore pHi to its original value. The most 
effective way to deal with this is through membrane-bound transporters that operate 
with a slower time course. Most cells have one or more types of Na+-driven 
antiporters in their plasma membrane that help to maintain the pHi. These proteins use 
the energy stored in the Na+ gradient to pump out excess H+. 
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 I.4.a. Plasma membrane pHi regulators 
Several transport proteins within the cell membrane are specialized to actively 
transport acids and bases across the membrane. Two mechanisms are used: either H+ 
is directly transported out of the cell or HCO3- is brought into the cell to neutralize H+ 
in the cytosol. There are three major classes of transporters in mammalian cells. Na+-
H+ exchanger (NHE) responds to cellular acidification by extruding H+ ions out of the 
cell in exchange for Na+. Second class of membrane transporters includes HCO3- 
dependent transporters (Cl--HCO3- exchanger, Na+- HCO3- cotransporter). Na+-driven 
Cl--HCO3- exchanger couples an influx of Na+ and HCO3- to an efflux of Cl- and H+ 
(so that NaHCO3 comes in and HCl goes out). A Na+-independent Cl--HCO3- 
exchanger also has an important role in pHi regulation. Like the Na+-dependent 
transporters, the Cl--HCO3- exchanger is regulated by pHi but the movement of HCO3-
, in this case, is normally out of the cell, down its electrochemical gradient. 
Third class of membrane-bound transporters comprises of H+-ATPases or proton 
pumps. Except for H+-ATPases, none of the carriers has a direct requirement for ATP 
(Molecular Biology of the Cell 4th ed. 2002). 
In a given situation, pHi regulation would depend upon a balance between the rate of 
acid generation and its elimination or extrusion from cell. Steady state pHi is given by 
the balance between acid production, acid efflux and acid influx (Leem et al, 1999). 
When cells are faced with an acid load or challenge various mechanisms to maintain 
pHi come into effect. 
Indeed, several studies have demonstrated that active extrusion of H+ by the Na+-H+ 
exchanger (NHE) is one of the major regulatory mechanisms used by most if not all 

































Fig. F. Various plasma membrane-bound pHi regulators. 
 
(A) H+-lactate co-transporter, (B) H+ Channel, (C) Cl--HCO3- exchanger, (D) Na+-H+ 

















regulator in transformed cells. NHE isoform 1 which is ubiquitously expressed in 
most mammalian cells has been extensively studied. 
 
I.5. Na+-H+ Exchanger (NHE) 
The Na+-H+ exchangers (NHEs) are a family of membrane glycoproteins which 
transport H+ out of the cell in exchange for Na+ with a stoichiometry of 1:1. In 
mammalian cells, the NHE family consists of nine isoforms, NHE-1 to NHE-9. 
Whereas most of the isoforms are restricted in their distribution and function, NHE-1, 
the first one of the isoforms to be cloned, is ubiquitously distributed (Sardet C et al, 
1989; Brett CL et al, 2002; Goyal S et al, 2003; Numata M and Orlowski J, 2001; 
Putney LK et al, 2002). NHE1 is discussed in detail in the next sections. Unlike 
NHE1, other isoforms are restricted in their subcellular and tissue distribution. 
The isoforms NHE2 to NHE5 are located in plasma membrane but have specific 
tissue distribution patterns. NHE2 and NHE3 are primarily located in apical 
membrane of epithelia, being most abundant in stomach and intestine (Collins JF et 
al, 1993; Wang Z et al, 1993). NHE3, in addition, is also found in kidney. NHE4 is 
expressed predominantly in stomach, kidney medulla, and hippocampus (Bookstein C 
et al, 1997). NHE5 is most abundant in brain but is also present in other non-epithelial 
tissues including spleen, skeletal muscle and testis (Orlowski J and Grinstein S, 
1997). 
The remaining four isoforms of NHE (NHE6 to NHE9) are distributed in intracellular 
compartments in humans. Mostly they are localized in Golgi and post-Golgi endocytic 
compartments. Recently it has been proposed that these isoforms contribute to the 
maintenance of the unique acidic pHs of the Golgi and post-Golgi compartments in 
the cell (Numata M and Orlowski J, 2001; Norihiro N et al, 2005). 
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 I.5.a. NHE1: Basic Structure 
NHE1 is the housekeeping protein which is present in most of the cells, if not all. It’s 
a membrane glycoprotein of approximately 100 kDa containing around 815 Amino 
Acids (membrane domain of about 500 amino acids and a large cytoplasmic “tail” of 
about 300 amino acids). Homology of NHE1 across various species is very high, but 
for the other isoforms (NHE2-NHE9) homology varies between 25-70%. NHE1 
displays inhibition by diuretic amiloride and its derivatives. It has twelve 
transmembrane domains, with both N- and C- terminals in the cytosol. C-terminal 
forms a long tail which contains binding sites for many regulatory proteins and a 
putative phosphorylation site (Fig. F), however the exact structural details of NHE1 
still remain unknown (Hunte C et al, 2005). 
Several of the transmembrane (TM) domains of NHE1 are important in its function 
(Fleigel L, 2005). TM IV seems to be the most important segment for NHE1’s affinity 
for Na+ and its sensitivity to NHE1 inhibitors. TM VI and VII are important for 
activity, and TM XI is essential in targeting NHE1 to the cell membrane. NHE1 
protein once synthesized in the cell undergoes posttranslational modifications, mainly 
glycosylation, before being targeted to the cell membrane. The large cytoplasmic 
“tail” of NHE1 has a putative phophorylation site and binding sites for various 
regulatory proteins. Kinases known to phosphorylate NHE1 include Erk 1/2, p90rsk, 
p160 ROCK, p38 and Nck-interacting kinase (Khaled AR et al, 2001; Tominaga T 
and Barber DL, 1998). The Na+/H+ exchanger is maximally active at low intracellular 
pH (pH <6.5). Its activity declines as the intracellular pH increases and binding of 


























































Fig. G. Structure of mammalian NHE-1. 
 
Topology of the NHE1 is shown after Wakabayashi et al. (2000). It’s a large protein 
having 12 trans-membrane domains. Tentative binding sites of some important 
regulatory proteins on long cytoplasmic “tail” are shown. The region of 
phosphorylation by regulatory kinases is also indicated. 
IL, Intracellular Loop; EL, Extracellular Loop; CaM, Calmodulin; CHP, Calcineurin 
Homologous Protein; ERM, Ezrin Radixin and Moesin; TC, Tescalcin. 
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I.5.b. NHE1: Major Functions 
I.5.b.i. pHi and cell volume regulation 
Na+/H+ exchange activity is centrally important in many physiological processes, the 
most important role being regulation of intracellular pH. The Na+/H+ exchanger is 
stimulated by a drop in intracellular pH. Activation of NHE leads to increased acid 
extrusion from the cell resulting in cytoplasmic alkalinization. The energy of Na+ 
gradient is used to catalyze the electro-neutral exchange of one Na+ for one H+. In 
doing so NHE also plays an important role in cell volume regulation after osmotic 
shrinkage (Shrode L et al, 1996). Upon exposure of cells to hyperosmotic solutions, 
Na+/H+ exchanger shows increased activity that result in cytosolic alkalinization and 
increase in cell volume. Although NHE1 is not the only one to regulate cell volume, it 
plays an important role in cell volume regulation. 
I.5.b.ii. Cell proliferation and differentiation 
Na+/H+ exchanger’s role in cell proliferation has been long known. In addition to 
protecting cells from intracellular acidification, NHE has also been shown to initiate 
shifts in pHi that stimulate growth of cells and plays a role in malignant 
transformation (Reshkin SJ et al, 2000).  
Although NHE1 has been long associated with cell proliferation but the exact 
mechanism remains unknown. In a recent study, NHE1 activity and pHi have been 
shown to regulate the timing of G2/M entry and transition, thus affecting the cell cycle 
(Putney LK and Barber DL, 2003). 
Increased activity and increased levels of expression of NHE are also important in cell 
differentiation (Rao GN et al, 1993; Dyck JRB and Fliegel L, 1995), however there 
are conflicting reports regarding the causal relationship of increased promoter activity 




























































Fig. H. Physiological Functions of NHE-1. 
 
Figure adapted from Larry Fliegel (2005). (A) pH regulation, (B) Hormones like 
epidermal growth factor (EGF) and angiotensin II (Ang II) can activate NHE1. This 
leads to increased cell growth and cell differentiation. (C) Activation of NHE1 during 
ischemia and reperfusion results in increased [Na+] inside the cell that leads to 
increased intracellular [Ca++] through the Na+/Ca+ exchanger (NCE) and ultimately 
cell damage and cell death. This is the mechanism proposed for myocardial damage. 
(D) NHE1 binding to ERM proteins regulates cytoskeleton and plays an important 
role in cell migration. 
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I.5.b.iii. Cell motility 
Interestingly, NHE1 has been found to play other key roles in the cell. It acts as a 
structural anchor that is involved in organization of the cytoskeleton (Denker SP et al, 
1998), thus playing an integral role in cell shape and movement. Actin filaments play 
a pivotal role in determining the shape and motility of a cell and also associate with 
the dynamic extensions like lamellipodia (Lagana A et al, 2000). NHE1 interacts 
directly to actin-binding proteins ezrin radixin and moesin (ERM) (Denker SP et al, 
2000). Regulation of cell volume and shape may be an important factor in 
determining the metastatic potential of a tumor.  
I.5.b.iv. As a plasma membrane scaffold 
In addition to its function as pHi/ cell volume regulator, and cytoskeletal interaction, a 
third major function of NHE1 has been recently proposed. Like other integral 
membrane proteins, NHE1 may act as plasma membrane scaffold in the assembly of 
signaling complexes (Baumgartner M et al, 2004). Some very important proteins that 
interact with NHE1 include phosphotidylinosotol 4, 5-bisphosphate (PIP2); 
calmodulin (CaM); ezrin, radixin and moesin (ERM); heat shock protein 70 (Hsp70), 
Rho kinase 1 (ROCK1) and p90-ribosomal protein S6 kinase (p90-RSK). NHE1 
promotes protein interactions, assembles signaling complexes in specialized 
membrane domains, and coordinates divergent signaling pathways. 
I.5.b.v. Cell injury 
NHE1 has been most extensively studied for its role in heart muscle. NHE1 gets 
activated when there is ischemic injury to the myocardium. This activity is more 
pronounced during the phase of re-perfusion. Increased Na+ that gets accumulated in 
the cell activates the Na+/Ca++ exchanger. Na+ then leaks out of the cell in exchange 
for Ca++ ions. Increased concentration of Ca++ ions in the myocardium leads to cell 
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injury and death. Because of this function of NHE1, many NHE1 selective inhibitors 
have been designed and some have even entered into clinical trials. Major known 
functions of NHE1 are summarized in Fig. D. 
 
I.5.c. NHE1: Regulation 
Although fluxes through the NHE are driven by chemical gradients of Na+ and H+ and 
do not require energy, the increase in transport activity of NHE1 is often associated 
with phosphorylation of a number of serine residues within the distal C-terminal 
cytoplasmic domain. The major intracellular signal that leads to increase in NHE1 
activity is an increase in H+ concentration (Lacroix J et al, 2003). In addition, there 
are sites for binding to various proteins. Important regulatory proteins that have been 
found to bind to NHE1 C- terminal include calmodulin (Bertrand BS et al, 1994), 
HSP70 (Silva NL et al, 1995), tescalcin (Li et al, 2003), carbonic anhydrase II (CAII) 
(Putney LK et al, 2002), and CHP, a calcineurin homologue (Lin and Barber, 1996). 
Associated proteins or lipids are likely to affect NHE activity, for example calmodulin 
and CAII are stimulatory whereas tescalcin is inhibitory to NHE1 activity.  Binding of 
regulatory proteins may also shift the pH dependence of NHE1 activity to a more 
alkaline range. One important fact to remember is that these regulatory proteins may 
themselves be subject to phosphorylation. Polyphosphoinositides are ubiquitous 
constituents of plasma membrane, where they have been shown to exert modulatory 
effect on the activity of many ion transporters. Phosphotidylinositol 4,5-bisphosphate 
(PIP2) is an important member of this family. Recently, it was shown that PIP2 exerts 
a regulatory role on NHE1 even in ATP-depletion conditions (Aharonovitz O et al, 
2000). Members of the ezrin/radixin/moeisin (ERM) family were recently reported to 
interact with NHE1 (Denker SP et al, 1998), and it is known that they are also capable 
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of binding to PIP2. Therefore PIP2 may play an important role in regulating NHE 
activity either by its direct binding or through ERM proteins. 
However, there is strong evidence that NHE1 activity is regulated by phosphorylation 
dependent as well as -independent mechanisms (Putney LK et al, 2002). This has 
been elegantly demonstrated in experiments where NHE1 phosphorylation was 
abolished by deletion of the C-terminal serine residues. When subjected to growth 
factor stimulation, cells expressing the C-terminal truncated NHE1 still retained up to 
50% of the transport activity, and were completely insensitive to the change in 
activity following osmotic shrinkage (Putney LK et al, 2002). In addition, kinase-
independent activation of the antiporter is further corroborated by findings that ATP 
depletion does not completely block acid stimulated NHE-1 activity (Cassel D et al, 
1986). A more direct evidence to support dynamic regulation of NHE1 transcription is 
provided by several reports, e.g. (a) upon growth factor in vascular smooth muscle 
cells (Rao GN et al, 1992), (b) by acid in renal epithelial cells (Moe OW et al, 1991), 
(c) during respiratory and metabolic acidosis in rat kidney cells (Krapf R et al, 1991), 
(d) with phorbol ester-induced differentiation (Rao GN et al, 1991), and (e) during the 
process of cellular proliferation (Grinstein S et al, 1989; Rotin D et al., 1989). 
 
I.5.d. NHE1: Regulation of gene expression 
NHE1 gene is located on chromosome 1 in humans, spans approximately 70 
kilobases. The coding region is divided into 12 exons and 11 introns. The 
promoter/enhancer region contains a TATA box, four GC boxes, two CAAT boxes, 
three AP-1 sites and a cyclic AMP response element (Miller RT et al, 1991). NHE1 
gene shows high homology across various species; mouse NHE1 gene is more than 
90% homologous to human gene. 
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Various studies have shown that NHE mRNA levels are increased in response to 
chronic acid loading and different experimental triggers that lead to cellular 
differentiation. Mitogenic stimulation of NHE1 leads to increased gene transcription 
and increased expression of NHE1 protein on cell surface (Besson P et al, 1998). 
Other evidences have suggested that mRNA levels of the exchanger are increased 
during cellular proliferation in intact tissues (Elsing C et al, 1994). 
Transcription factor AP-2 or an AP-2-like protein has been shown to be involved in 
regulation NHE1 gene during differentiation of P19 cells (Dyck JRB and Fliegel L, 
1995). The AP2 transcription factor family is a set of developmentally regulated, 
retinoic acid inducible genes composed of four related factors AP2α, AP2β, AP2γ, 
and AP2δ. AP2 factors orchestrate a variety of cell processes including apoptosis, cell 
growth, and tissue differentiation during embryogenesis. They have also been shown 
to regulate the expression of genes in various tissues and tumors. Several lines of 
investigation have led to the conclusion that AP2 is a tumor suppressor gene. 
Recent cloning of NHE1 gene has allowed better insights into the regulation of NHE1 
promoter. Scientists have observed that a step-wise reduction in the 5’ end of the 
NHE1 promoter leads to a gradual reduction of promoter activity; however, this effect 
varies amongst different cell types. In addition, DNA foot-printing experiments have 
suggested that many regions of the promoter bind proteins of nuclear extract (Kolyada 
AY et al, 1994; Yang W et al, 1996). A highly conserved poly (dA.dT)-rich region 
also seems to play an important role in regulation of NHE1 expression (Yang W et al, 
1996). Several putative proximally acting transcription factors are involved in 
regulation of basal NHE1 expression including AP-1, AP-2 and C/EBP (Dyck JRB 
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Fig. I. Basic structure of proximal part of NHE1 promoter (Highlighting the 
various truncated regions of promoter used in this study). There is >90% 
homology between mouse and human NHE1 gene. 
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In addition to AP-2, several other transcription factors have been proposed. One such 
group is the chicken ovalbumin upstream promoter-transcription factor (COUP-TF). 
COUP-TFs are orphan receptors involved in regulation of embryonic development 
and neuronal cell fate determination. COUP-TF I and II regulate NHE1 gene 
expression through a nuclear hormone responsive element in NIH3T3 and L6 cells 
(Fernandez-Rachubinski F et al, 2001).  
Recent studies have also shown that the Na+/H+ exchanger is regulated in response to 
thyroid hormone. Reduction in circulating thyroid hormone levels reduces the amount 
of both protein and mRNA of NHE1. The NHE1 promoter contains a TR-α1 binding 
site. This regulation of the NHE1 promoter by thyroid hormone is proposed to be 
responsible for postnatal changes in expression of the Na+/H+ exchanger (Slepkov E 
and Fliegel L, 2004) 
In summary, mitogenic signals that lead to cell growth also lead to NHE1 gene 
activation. Many transcription factors that are important during cell development and 
differentiation activate NHE1 gene. Evidence suggests that NHE1 activation at both 
transcription and protein level plays an important role in regulating its function. 
 
I.5.e. NHE1: Pathological Functions 
1.5.e.i. Role in Myocardium 
Much work on NHE1 has been done in context to its possible role in mammalian 
heart. Evidence suggests the pH regulation activity of NHE1 plays a significant role in 
mediating the damage that occurs to the human myocardium during ischemia and 
reperfusion. Increased NHE1 activity during ischemia results in accumulation of 
intracellular Na+ which in turn results in reduction of Ca2+ extrusion by the Na+/Ca2+ 
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exchanger (Karmazyn M et al, 1999). Excess Ca2+ therefore accumulates in the cell 
and causes cell necrosis, contracture and cardiac arrhythmias. 
Amiloride (a K+-sparing diuretic), in addition to its ability to block a conductive Na+ 
channel and the Na+/Ca++ exchanger, was the first drug described as NHE inhibitor. In 
a bid to develop more selective NHE1 inhibitors many amiloride derivatives have 
been designed. Later, several acylguanidines were prepared with even greater potency 
and NHE selectivity, including HOE-694, cariporide and eniporide (Masereel B et al, 
2003). Amiloride derivatives and other NHE inhibitors were found successful in 
blocking the damage to myocardium in animal models. 
However, a recent clinical trial, the GUARDIAN trial, showed that cariporide (a 
selective NHE1 inhibitor) provides cardioprotective effect only in one subgroup of 
patients, those with coronary artery bypass surgery (Avkiran M and Marber MS, 
2002). Further validation of NHE1 inhibitors as cardioprotective agents following an 
ischemic event in the heart is ongoing. 
1.5.e.ii. NHE1: Role in Tumorigenesis 
Several studies have shown both increased message and protein of NHE1 in 
transformed cells. Apart from its role as a principal regulator of pHi and cell volume, 
NHE1 has been implicated in cell proliferation and transformation, thereby linking 
alkaline intracellular milieu with processes of proliferation and transformation 
(Putney LK et al, 2002). Rapid stimulation of the NHE1, with consequent alkaline 
pHi, appears to be a universal response of quiescent cells to growth-promoting factors 
and mitogens (Schuldiner S and Rosengurt E, 1982; Cassel D et al., 1983; Moolenaar 
WH et al, 1983; Mills GB et al, 1985). Moreover, tumor cells deficient in Na+/H+ 
exchange activity either fail to grow or show severely retarded growth when 
implanted in immuno-deficient mice (Rotin D et al, 1989). It also might play a role in 
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moderating apoptosis, at least in human leukemic cells (Rich IN et al. 2000). With 
respect to Fas receptor-induced apoptosis, a recent study has demonstrated that the 
related cytoplasmic acidification is partly due to inhibition of NHE1 (Lang F et al, 
2000). The phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) has been long 
known to induce intracellular alkalinization via NHE1 activation in various cells. It 
has recently been reported to rescue T lymphocytes from Fas-mediated apoptosis via 
activation of p90rsk, resulting in phosphorylation and inactivation of BAD, a 
proapoptotic member of Bcl-2 family. 
In an in vivo study, when Ras-transformed fibroblasts were implanted in nude mice 
very interesting observations were made (Pouyssegur J et al, 2001). Ras-transformed 
pgi- cells (not forming lactic acid) formed tumors like wild type transformed cells 
(100% incidence). The disruption of NHE1 however, strongly reduced tumor 
incidence to about 20%. This study lead to the conclusion that over-production of 
lactic acid is detrimental for tumor development and that NHE1, by controlling pHi, 
plays a key role in cell survival/proliferation and tumor growth. 
Paclitaxel, a well known chemotherapeutic drug, was recently shown to induce 
apoptosis in breast cancer cells in an NHE1-dependent fashion (Reshkin SJ et al, 
2003). In this model, paclitaxel treatment resulted in activation of protein kinase A 
and p38 MAPK, and inhibited the activity of NHE1. Paclitaxel belongs to the 
“texanes” group of anti-cancer drugs which are active against cancers that are 
refractory to other types of chemotherapy. Major mode of action of taxanes is thought 
to be their ability to bind to tubulin leading to G2/M arrest of the cell and subsequently 
apoptosis. Down-regulation of NHE1 activity by using a specific inhibitor (DMA) 
synergistically potentiated the paclitaxel-induced apoptosis at very low 
concentrations. 
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Recently, it has been shown by Denker and Barber that NHE1 acts as a structural 
anchor and is involved in organization of cytoskeleton. This structural interaction of 
NHE1 with cytoskeleton is independent of its ion exchange function. This anchoring 
occurs via direct structural interaction of NHE1 with actin-binding proteins ezrin, 
radixin and moesin (Denker SP et al, 2000). 
Recruitment of ERM proteins by NHE1 regulates Akt-dependent cell survival (Karen 
LW et al, 2004). Cell migration is a multi-step process that requires spatial asymmetry 
which is stimulated by Rho GTPases, phosphoinositides and actin polymerization. 
Disrupting NHE1 function leads to impaired polarity of cells and their inability to 
migrate in response to these stimuli. However, this role in cell migration seems to 
require both ion translocation and cytoskeletal anchoring function of NHE1 (Denker 
SP and Barber DL, 2002b). The central role NHE1 plays in cell movement and 
migration has been proposed as a determining factor of the metastatic potential of a 
tumor (Cardone RA et al, 2005). 
pHi and cell volume regulation are the principle functions of NHE1. In addition, it has 
been shown to play a role in cell growth, motility, differentiation and transformation. 
However, in the light of recent advances in our understanding of NHE1 functions, it 
may not be wrong to speculate that the role NHE1 plays in tumor cells may or may 
not be a dependent on its pH regulatory function. 
 
I.6. Rac subfamily and NHE1 
Numerous studies support a role for the small GTPases of the Ras family in 
proliferation, transformation and NHE1 activation (Hooley R et al, 1996; Voyno-
Yasenetskaya T et al, 1994). Although, the signaling pathways acting downstream of 
these GTPases to stimulate NHE1 are distinctly different, they all lead to the 
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activation of kinases. For example, Gαq acts through a protein kinase C-dependent 
mechanism, Ras acts through a Raf-1 and mitogen-activated protein kinase kinase 
(MAPK)-dependent mechanism and Gα13 employs a MEK kinase (MEKK1)-
dependent mechanism for NHE-1 stimulation. In addition, GTPases of the Rho 
family, Rac, Cdc42 and Rho also mediate Gα13 activation of NHE1 through 
phosphorylation of the exchanger (Denker SP et al, 2000a and 2000b; Hooley R et al, 
1996; Lin X and Barber DL, 1996; Tominaga T and Barber DL, 1998). 
However, considering the fact that induction of proliferation and transformation by 
Rho GTPases occurs over a longer time-scale compared to the short-term changes of 
the actin cytoskeleton and the implication that these events require transcriptional 
activation, it is plausible that the small GTPases such as Rho, Rac or Cdc42 directly 
or indirectly influence gene transcription. 
 
I.7. Conclusion 
In summary, NHE1 is a ubiquitously expressed protein in most cells and it performs 
at least three important functions in a cell: 1) Intracelullar pH/ Cell volume regulation; 
2) acts as a cytoskeletal anchor by its direct interaction with ERM proteins; and 3) as 
a membrane scaffold in the assembly of signaling complexes. Tumor cells display 
increased expression and activity of NHE1. NHE1 has been implicated in cell 
proliferation, survival, and transformation, although the exact mechanism remains 
largely unknown (Putney LK et al, 2002). Growth factors such as serum, EGF and 
phorbol ester myristyl acetate (PMA) have all been shown to activate NHE-1 
promoter activity (Besson P et al, 1998). In addition, another characteristic of tumor 
cells is a higher metabolic rate and an altered redox state. A slight pro-oxidant 
intracellular environment also shares the pro-survival and proliferative properties of 
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NHE1. Involvement of ROS in NHE1 activation merits to be investigated as phorbol 
esters have been shown to activate NHE1 by O2.- (Shibanuma M et al, 1988). AP-2 
transcription factor that has been shown to regulate NHE1 gene expression belongs to 
the family of redox-regulated transcription factors. Intracellular alkalinization seems 
to be an upstream event in the apoptotic cascade, and upon initiation of apoptosis, is 
followed by intracellular acidification. The model that we propose is of a long-term 
maintenance of an alkaline pHi (for example by adjusting the pH set-point of NHE1 
to a higher pH) in a tumor cell. 
So, our question simply was whether their exists any functional relationship between 
increased O2.- production in the cell and regulation of NHE1 expression. And if so, 




Materials and Methods 
 
II.1. Chemicals 
Lucigenin, staurosporine, diphenylene iodonium (DPI), Diethylthiocarbamate (DDC), 
5-(N-Ethyl-isopropyl) amiloride (EIPA), Nigericin and crystal violet were obtained 
from Sigma Chemical Co (St Louis, MO), etoposide from Clonetech Laboratories, 
Inc. (Palo Alto, CA). Etoposide, staurosporine and DPI were diluted in 
dimethylsulfoxide (DMSO). Stock solutions were at least 1000x. 1/1000 dilutions of 
DMSO did not alter cell viability or interfere with apoptotic cell death. Hydrogen 
peroxide (H2O2) was from Merck. Cm- BCECF was from molecular probes. 
 
II.2. Cells 
All cell lines used in this study were adherent cells, and for most of the assays cells 
were used at around 70% confluency. NIH3T3 mouse fibroblast cells were maintained 
in RPMI medium supplemented with 10% fetal bovine serum (Hyclone, Irvine, CA), 
1% glutamine and 0.5% gentamicin (Gibco-BRL, Gaithersburg, MD, USA). 
NIH3T3 cells stably transfected with a 1.1-kb proximal fragment of the mouse NHE1 
promoter/enhancer inserted 5′ to a luciferase gene (NIH3T3 1A8 and NIH3T3 Luc) 
(Besson et al., 1998) or a Chloramphenicol Acetyl Transferase (CAT) gene (NIH3T3 
CatC2 and NIH3T3 CatB3) (Besson et al., 1998) were maintained in Minimum 
Essential Medium (MEM) supplemented with 10% fetal bovine serum (Hyclone, 
Irvine, CA), 1% glutamine, 0.5% gentamicin (Gibco-BRL, Gaithersburg, MD, USA) 








NIH3T3 Mouse Normal Fibroblast RPMI - 
NIH3T3 1A8 Mouse Normal Fibroblast MEM G418 
NIH3T3 Luc Mouse Normal Fibroblast MEM G418 
NIH3T3 B3 Mouse Normal Fibroblast MEM G418 
NIH3T3 C2 Mouse Normal Fibroblast MEM G418 
     
MCT Mouse Normal Renal Tubular 
Epithelial Cell 
RPMI - 
     
L6 Rat Normal Myoblast DMEM - 
     
M14 pIRES Human Malignant Melanoma DMEM Hygromycin
M14 RacV12 Human Malignant Melanoma DMEM Hygromycin
     
U87 Human Malignant Glioblastoma RPMI - 
     
LNCaP Human Malignant Prostate Cancer RPMI - 
     
 
Table 1. Various Cell Lines used in the project. 
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Mouse kidney tubular epithelial cells stably transfected with a 1.1-kb proximal 
fragment of the mouse NHE1 promoter/enhancer inserted 5’ to a luciferase gene 
(MCT 1.1kb) were maintained in RPMI medium supplemented with 5% fetal bovine 
serum (Hyclone, Irvine, CA), 1% glutamine, 0.5% gentamicin (Gibco-BRL, 
Gaithersburg, MD, USA) and 0.25mg/ml G418 (Roche Diagnostics Corporation, In, 
USA). 
Rat muscle cell lines stably transfected with a varying length of proximal fragment of 
the mouse NHE1 promoter/enhancer inserted 5’ to a luciferase gene (L6 1.1Kb, L6 
0.9Kb, L6 0.5Kb, L6 0.2Kb, L6 0.18Kb and L6 AP2+) (Yang et al., 1996) were 
maintained in DME medium supplemented with 5% fetal bovine serum (Hyclone, 
Irvine, CA), 1% glutamine, 0.5% gentamicin (Gibco-BRL, Gaithersburg, MD, USA) 
and 0.25mg/ml G418 (Roche Diagnostics Corporation, In, USA). 
M14 human melanoma cells stably transfected with a constitutive activated form of 
Rac1 (M14RacV12) or the vector control (M14pIRES) (Pervaiz et al., 2001) were 
maintained in DMEM supplemented with 10% fetal bovine serum (Hyclone, Irvine, 
CA), 1% glutamine, 0.5% gentamicin (Gibco-BRL, Gaithersburg, MD, USA) and 
Hygromycin (Roche). 
T24 human bladder carcinoma cell line was maintained in McCoy’s Modified 
Medium supplemented with 5% fetal bovine serum (Hyclone, Irvine, CA), 1% 
glutamine and 0.5% gentamicin (Gibco-BRL, Gaithersburg, MD, USA). 
U87 human malignant glioma cell line was maintained in RPMI medium 
supplemented with 10% fetal bovine serum (Hyclone, Irvine, CA), 1% glutamine and 




II.3. cDNA Plasmids and transfections 
The partial myc-tagged loss-of-function mutants of Rac1 containing specific amino 
acid substitutions in the activated RacV12 background used in this study were all 
cloned in the pIREShyg vector as described previously (Pervaiz et al., 2001). The 
pECE-NHE1 plasmid was obtained from Pouyssegur. 
All transfections were performed using CalPhosTM mammalian transfection kit 
(Clonetech Laboratories, Inc., Palo Alto, CA). In brief, 0.3x106cells/well were plated 
in 6-well plates 24 hours prior to transfection. Two hours before transfection, the cell 
culture medium was changed with DMEM supplemented with 5% FBS. To prepare 
the transfection mixture, 6 µg of DNA, (5 µg of the required plasmid and 1 µg of the 
pCMV β-gal plasmid) was diluted in sterile ddH2O in a microfuge tube, followed by 
the addition of 12.4 µl of 2.5 M CaCl2 in a total amount of 100 µl/well. Two solutions 
were prepared as following: 
 
Solution A DNA (6 μg) CaCl2 H2O 
  ? μl 12.4 μl To make up 100 μl 
 
Solution B 2 x HBS (HEPES Buffered Saline) 
 100 μl 
 
Solution A was than mixed drop-wise into solution B while gently vortexing. The 
transfection mixture was incubated at room temperature for 20 minutes. 
 
The mixture (200 μl) was added to the medium of each well drop-wise. Plates were 
shaken gently and put back in the incubator. This step was important because DNA 
precipitates are heavy in weight they may settle in the center or periphery of the well 
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rather than being distributed evenly. After 16 hours of incubation, cells were washed 
twice with 1 x PBS. Glycerol Shock was performed to enhance the transfection 
efficiency. Two ml of 15% glycerol in PBS was added per well for 90 seconds. Cells 
were quickly washed with PBS twice and normal medium was replaced. After 24-48 
hours of incubation, cells were harvested for appropriate assays. 
β-gal activity was measured using the Galacto-Star mammalian reporter Kit 
(TROPIX, Bedford, MA). 
 
II.4. β-Galactosidase Survival Assay 
Co-transfection of cells was done with pCMV-β plasmid encoding for the β-
galactosidase protein (β-gal). 16 hours later Glycerol Shock was done as described 
under transfection procedure. After 24 hours the apoptotic trigger was added for an 
additional 24 hours. Survival was calculated as: [(β-gal activity/µg of protein of 
transfected cells incubated with the apoptotic trigger)/(β-gal activity/µg of protein of 
transfected cells left for the same period without the apoptotic trigger)] x100. β-gal 
activity was measured using the Galacto-Star mammalian reporter kit. 
 
II.4a. Measurement of β-Galactosidase activity 
Lysate preparation: 
Culture medium was removed and cells were washed twice with 1X PBS. 200 ul of 
Cell Lysis Buffer was added per well. Cells were incubated in the lysis buffer at room 
temperature for 15 minutes. Cells were detached from the plate using a cell scraper 
and the lysate was transferred to 1.5 ml microfuge tube.  




Reaction Buffer was prepared by diluting Galacton-Star substrate 1:50 with Reaction 
Buffer Diluent. 10 ul of cell lysate was transferred to a luminometer tube and 300 ul 
of Reaction Buffer was added. The reaction mix was then incubated for 30 minutes at 
30 ºC. Light emission signal was then measured for 10 seconds using the Turner TD 
20/20 tube luminometer. 
 
II.5. siRNA transfection 
Transient siRNA transfections of cells were done using Oligofectamine (Promega). 
0.15x106cells/well were plated in 6-well plates (well diameter= 35 mm) 24 hours 
prior to transfection. (Cell density should be 40-50% at the time of transfection). 
Before starting the experiment, growth medium was removed and cells were washed 
once with PBS. 800ul of opti-MEM1 (without serum) was added per well and plates 
were put back in the incubator. 
To prepare the transfection mixture, two solutions were prepared first. For Solution A, 
200 μl of opti-MEM1 medium was added to a sterile microfuge tube and 6ul of 
siRNA was added to it and gently mixed. For Solution B, 6 μl of oligofectamine was 
added to 24 μl of opti-MEM1 in a separate microfuge tube. Solution A and B were 
mixed together gently by inverting and incubated at room temperature for 20 minutes. 
At the end of incubation period, 200 μl of transfection mixture was added drop-wise 
onto cells. 4 hours later, 500 μl of opti-MEM1 containing 3x the normal concentration 
of serum (which in case of NIH3T3 is 10% and M14 is 5%) was added per well. 
24 hours later medium containing transfection complexes was replaced with fresh 
medium. Cells were assayed for siRNA efficiency 72-96 hours post-transfection. 
Generally, siRNA transfection efficiency was around 80-90%. 
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Following sequence was used to silence NHE-1: 
5′- GAUAGGUUUCCAUGUGAUC 
For negative control transfection an inverted sequence of luciferase gene was used to 
design our Control siRNA: 
5′- AGCUUCAUAAGGCGCAUGCTT 
 
II.6. Luciferase reporter gene assay 
NHE-1 promoter activity in NIH3T3 1A8, MCT 1.1kb, L61.1kb was assessed using 
the luciferase reporter assay system according to the manufacturer’s instructions 
(Promega, Madison, WI). In brief, cell lysates were prepared using 200 µl/well of 
lysis buffer provided by the manufacturer. 20 µl of cell lysate was mixed with 100 µl 
of Luciferase substrate. Luminescence was measured for 10 seconds in a TD-20/20 
Luminometer (Turner Designs, Sunnyvale, CA).  
 
II.7. CAT (Chloramphenicol acetyltransferase) ELISA 
NHE-1 promoter activity was also assessed using an enzyme immunoassay to 
determine CAT expression. The Elisa assay was performed according to the 
manufacturer’s instructions (Roche Diagnostics Corporation, IN). 
0.3 x 106 cells were plated in 35 mm (6-well) plates. The next day cells were either 
transiently transfected or trigger added depending on the experimental conditions. 
On the day of CAT assay, medium was removed and cells were washed thrice with 
pre-cooled PBS. Colorimetric enzyme immunoassay for quantitative determination of 
CAT was done using CAT ELISA kit from Roche Inc. All steps were done as 
described by the vendor. Absorbance was measured at 405 nm (reference wavelength: 
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490 nm) using a microplate ELISA reader. Standard curve was drawn and CAT 
enzyme was calculated in samples as pg/ml. 
 
II.8. Measurement of steady state pHi 
pHi was measured by loading cells with the fluorescent pH indicator BCECF-AM 
(2’,7’-bis(2-carboxyethyl)-5,6-carboxyfluorescein; Molecular Probes, Eugene, OR).  
Cells were plated in 6-well plates, after 24 hours they were subjected to different 
treatments and/or transfections and after appropriate time pHi measurement was 
undertaken. Cells remained attached to the 6-well plates throughout the pHi 
measurement assay. Briefly, cells were washed once with HBSS (Sigma, St. Louis, 
MO) before being incubated in 1 ml of HBSS containing 10ml of 1mM BCECF-AM 
at 37˚C. Following 30 minutes incubation in the dark, cells were washed once with 
HBSS and fluorescence immediately measured in a Spectrafluor Plus (TECAN 
Austria, GmbH, Grödig, Austria) with the excitation wavelength at 485nm and 430 
nm, and emission at 535 nm. The ratio of BCECF fluorescence was then used to 
obtain pHi from a pH calibration curve. A pH calibration curve was generated for 
each cells treatment and pHi measurements were calculated from this reference curve. 
In order to generate a pH calibration curve, cells were loaded with BCECF-AM as 
above, washed once with HBSS and then resuspended in high K+ buffer (135mM 
KH2PO4, 20mM NaCl, and 110mM K2HPO4, and 20mM NaCl with a range of pH 
between 6.0 and 8.0). Immediately before measurement of BCECF fluorescence, cells 
were loaded with 10mM nigericin (1mM stock in absolute alcohol, Sigma, St Louis, 
MO), and fluorescence ratio measurements (535nm/595nm) of cells in nigericin-
containing buffers of a range of pH were then used to relate fluorescence ratio 
measurement to pHi. 
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 II.9. Measurement of acid load and pHi recovery (NHE-1 activity) 
Initial steps were similar to the protocol described in previous section. Cells were 
washed and incubated with 5 μM of BCECF-AM in HCO3--free HEPES buffer (135 
mM NaCl, 5 mM KCl, 1.8 mM CaCl2, 1 mM MgSO4, 5.5 mM glucose, 10 mM 
HEPES, pH 7.4) for 30 minutes at 37oC. The cells were washed and fluorescence of 
BCECF was measured (excitation at 485 nm and 430 nm; emission at 535 nm). pHi 
was derived by determining the ratio of dual excitation measurement (485 nm: 430 
nm) from a pHi standard curve. To calibrate the relationship between the excitation 
ratio (485 nm: 430 nm) and pH, cells loaded with 5 μM BCECF-AM were incubated 
with 10 μM nigericin for 3 minutes in high K+ buffer of pH 6.4-8.0, obtained by 
mixing pH 4 buffer (140 mM KH2PO4 and 20 mM NaCl) and pH 9 buffer (70 mM 
K2HPO4 and 20 mM NaCl) and fluorescence measurement was taken. After 
measurement of pHi, the cells were acid loaded with HCO3--free HEPES buffer 
containing 30 mM NH4Cl, pH 7.4 for 8 minutes (the osmolarity of this buffer has 
been adjusted). The cells were then exposed to Na+-free, HCO3--free HEPES buffer 
(135 mM N-methyl glucamine, 5 mM KCl, 1.8 mM CaCl2, 1 mM MgSO4, 5.5 mM 
glucose, 10 mM HEPES, pH 7.4) for 30 seconds and subsequently washed with 
HEPES buffer. The pH recovery from acid load was monitored for 15 minutes and 
NHE-1 activity was determined by the rate of pHi recovery.  
 
II.10. Western blot analysis of NHE-1 protein 
Cell lysates were prepared using 300 µl/well of RIPA/NP-40 lysis buffer (5 mM Tris 
pH7.4, 30 mM NaCl, 1 mM PMSF, 1 µg/ml aprotinin, and 0.5% NP-40). Lysate was 
denatured at 37˚C for 5 minutes, rather than the usual 95˚C. 300 µg of total protein 
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per sample was then subjected to 15% PAGE, transferred to nitrocellulose membrane 
and blocked 1 hour with 5% fat-free milk in Tris-buffered saline/0.05% Tween 20 
(TBST). After three washes with TBST, the membranes were exposed to a 1:2000 
dilution of a mouse anti-porcine NHE1 antibody (Chemicon International Inc., 
Temecula, CA, USA) at 4˚C overnight. The anti-NHE-1 antibody used here cross-
reacts with all vertebrate NHE-1 protein including human. Following three washes 
with TBST, the membrane was exposed to a 1: 10 000 dilution of goat anti-mouse 
IgG-HRP conjugate (PIERCE, Rockford, IL, USA) for 1 hour and washed repeatedly 
with TBST. Chemiluminescence was detected using the SuperSignal Substrate 
(PIERCE, Rockford, IL, USA). 
 
II.11. Measurement of intracellular superoxide 
A lucigenin-based chemiluminescence assay was used for the detection of 
intracellular O2- as described previously (Pervaiz and Clement, 2002). Briefly, cells 
were washed once with PBS, trypsinized, and centrifuged at 2000xg at room 
temperature for 1 minute. Pellets were resuspended and cells permeabilized in 400µl 
of 1X somatic cell ATP releasing reagent (Sigma-Aldrich, St. Louis, MO). 100 µl of 
850µM lucigenin solution was injected automatically before the reading. 
Chemiluminescence was monitored for 180 seconds in a TD-20/20 Luminometer 
(Turner Designs, Sunnyvale, CA). 
 
II.12. Crystal Violet Assay 
Culture medium was removed from 6-well plates by flicking. Cells were washed once 
with 1 ml of 1xPBS per well. 500 µl of Crystal Violet solution was added per well 
and incubated for 10 minutes at room temperature. Crystal Violet solution was then 
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removed by flicking the plate and wells were washed with tap water several times to 
get rid of the extra crystal violet solution. Plates were left to dry overnight. 1 ml of 
1xPBS/1%SDS solution was added per well and left for 4 hours. Absorbance was then 
measured at 595 nm using a plate reader. 
 
II.13. Caspase assay 
Cells were lysed in 50 µl of chilled cell lysis buffer (10 mM Herpes, pH7, 4.2 mM 
EDTA, 0.1% CHAPS, 5 mM DTT, 1 mM PMSF, 10 µg/ml aprotinin, 10 µg/ml 
pepstatin A, 20 µg/ml leupeptin) and incubated on ice for 10 minutes. Then, 40 µl of 2 
x reaction buffer containing 10 mM DTT and 4 µl of 1 mM synthetic oligopeptide 
caspase 3, 7, 10 substrate DEVD-(7-amino-4-trifluoromethyl coumarin) (DEVD-
AFC) were added to each sample and incubated at 370C for 1 hour. Fluorescence was 
measured at excitation wavelength of 530 nm and emission wavelength of 485 nm 
inside spectrofluorometer. Protein concentration was determined using the coomasie 
plus protein assay reagent from Pierce (Pierce Chemical Company, Rockford, IL, 
USA). 
 
II.14. Statistical Analysis 







III.1.a Regulation of NHE-1 gene expression regulates cells’ response to death 
triggers in NIH3T3 cells 
The predominant function of NHE-1 is the regulation of intracellular pH (pHi). 
However, recent evidence strongly suggest that, in addition to regulating pHi NHE-1 
could be a critical regulator of cells’ sensitivity to death signals (Reshkin SJ et al, 
2003; Wu KL et al, 2003). In order to test this observation in our system, NIH3T3 
cells were transfected with increasing concentrations of pECE-NHE1 vector. In order 
to assess transfection efficiency as well as to calculate cell survival, cells were co-
transfected with the pCMV-βGal plasmid which encodes for β–Galactosidase protein. 
β-Gal assay was used to assess cell death as it allows for the measurement of cell 
death in trasfected cells only (Pervaiz S et al, 2001). Cells were co-transfected with 
the pCMV-βgal plasmid and either the pIREShyg empty vector (pIRES) as control or 
pECE-NHE1 (different concentrations). Using expression of β-gal as a marker, only 
transfected cells are analysed for response to apoptotic stimuli as non-transfected cells 
are excluded in assessment. Forty-eight hours post-transfection, sensitivity to 
apoptosis of pIRES or pECE-NHE1 transfected cells was assessed by measuring the 
β-gal activity in cells incubated with or without 0.5 µM staurosporine for an 
additional 18 h. Per cent survival was calculated as the (β-gal activity of transfected 
cells incubated with the drug/ β-gal activity of transfected cell incubated without the 
drug) x 100. 
Fig 1A shows western blot analysis of NIH3T3 cells 48 hours post-transfection. With 
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Figure 1. Increased NHE-1 expression leads to inhibition of staurosporine-
induced cell death in NIH3T3 cells. 
NIH3T3 cells were co-transfected with increasing concentrations of the pECE vector 
encoding for the human NHE-1 cDNA (empty vector pIRES cDNA was added 
corresponding to varying pECE-NHE1 cDNA in order to keep the total cDNA amount 
constant) and 0.5μg of pCMVβ plasmid encoding for β-galactosidase as described in 
Materials and Methods. (A) Fourty-eight hours post transfection level of NHE-1 
expression was assessed by western blot analysis. Gel represents one transfection out 
of three. (B) Band intensity of NHE-1/β actin + SE from three different trasnfections 
has been averaged as % of pIRES transfected cells.  
(C) Cell death of NHE-1-transfected cells upon incubation with 0.5 μM staurosporin 
for 18 hours was assessed using the β-gal assay as described in Materials and 
Methods. Cell Death was calculated as [(β-gal activity/ µg of protein of transfected 
cells incubated with staurosporine)/(β-gal activity/µg of protein of transfected cells 
incubated without staurosporine)]x 100. Results are shown as mean of 3 experiments 
+ SE. * P < 0.02 
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was observed (Fig 1B). When these cells were incubated with staurosporine for 18 
hours and cell death was assessed by β-Gal assay, it can be seen in Fig 1C that dose-
dependent increase in NHE1 protein expression correlated with the inhibition of 
staurosporine-induced cell death. 
On the other hand, silencing of NHE1 gene was obtained by transfecting NIH3T3 
cells with a specific NHE1 siRNA. Using siRNA to silence the target gene is being 
increasingly used as a molecular tool. It has proven to be a simple yet powerful tool to 
study functional genomics. In this technique, a short length RNA sequence (usually 
21-23 amino acids) is designed to match the sequence of target gene (Elbashir SM et 
al, 2002). The siRNA binds to the target mRNA sequence and leads to its degradation 
thus leading to a functional knockdown of the gene of interest. 
Following sequence was used to silence NHE-1: 
5′- GAUAGGUUUCCAUGUGAUC 
A Control siRNA (Co siRNA) sequence was used as a negative control for the 
experiment. The sequence for Control siRNA must be designed as such that it does 
not recognize any mammalian mRNA. We used an inverted sequence of luciferase 
gene to design our Control siRNA (Co siRNA): 
5′- AGCUUCAUAAGGCGCAUGCTT 
Fig 2A shows that upon transfection of NIH3T3 cells with the NHE1 siRNA, there 
was a significant drop in NHE1 expression level. Interestingly and as expected, 
decreased NHE1 expression led to increased sensitivity of the cells to staurosporine 
and etoposide-induced cell death (Fig 2B). Staurosporine and etoposide are well-
documented triggers of apoptotic cell death. The doses of these drugs that were used 





















Figure 2. Silencing of NHE-1 gene leads to increased susceptibility to cell death 
in NIH3T3 cells. 
Silencing the NHE-1 gene further supports a role for NHE-1 expression in cell 
response to apoptotic triggers. NIH3T3 cells were transfected with either Control 
siRNA (Co siRNA) or NHE1 siRNA (NHE1 siRNA) and pCMV-βgal cDNA. Fourty-
eight hours post-silencing (A) western blot analysis was done and (B) cell death was 
triggered for 18 hours with either 0.5 μM staurosporine (Sts) or 40 μM etoposide 
(Eto) before being assessed using the β-gal assay. Cell death was calculated as [(β-gal 
activity/µg of protein of transfected cells incubated with staurosporine or etoposide) 
/(β-gal activity/µg of protein of transfected cells incubated without drugs)]x100 










Figure 3. Manipulation of NHE-1 gene expression affects cells’ sensitivity to 
death triggers in NIH3T3 cells. 
This figure shows a consolidation of data from Fig 1C and 2B. Staurosporine was 








































































































































































et al, 2001). This was to avoid sudden and necrotic type of cell death and mimic 
physiological conditions more closely.  
Initially cell death was assessed at various time points starting from 6 hours uptill 24 
hours. Eighteen hours time point was chosen for further experiments as it showed 
significant difference in cell death response. 
One important point to not here is that β-Gal survival assay is particularly useful in 
NHE-1 over-expressing experiment because the transfection efficiency obtained in 
cDNA trasfection experiments is generally agreed upon to be around 30%. On the 
contrary siRNA transfection generally yields a transfection efficiency of around 90%. 
β-Gal assay was used to assess cell death in both cDNA and siRNA transfection 
experiments. This was done purposely so that results obtained from both experiments 
could be compared to each other and could give a better index in terms of % cell 
survival. Thus, looking at the results from NHE1 over expression and silencing it can 
be deduced that cell death in response to staurosporine can vary from as low as 15% 
to 48%, depending on the level of NHE-1 protein expression (Fig 3). 
Although no specific assays were performed to assess cellular proliferation, but 
simple observation of cells showed that silencing with NHE-1 siRNA did not result in 
any significant decrease in cell proliferation. This could be due to the fact that 
silencing NHE-1 with siRNA does not completely abolish NHE-1 protein (as opposed 
to NHE-1 knock out), and the effect of NHE-1 on proliferation could be independent 
of its cell survival function. 
 
III.1.b Regulation of NHE-1 gene expression regulates cells’ response to death 
triggers in Tumor cells 
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Studies have demonstrated increased mRNA and protein levels of NHE-1 in 
transformed cells as compared to their normal counterparts. Reshkin et al. have 
recently demonstrated that NHE-1 protein expression is implicated in malignant 
transformation and the development of the transformed phenotype (Reshkin SJ et al, 
2000). Thus, we decided to look at NHE-1 expression profile in tumor cells and see 
whether manipulation of its expression will have an effect on death sensitivity of 
these cells. Two tumor cell lines were used, U87 and LNCaP. U87 is a cell line 
derived from human glioblastoma which is one of the most aggressive and difficult to 
treat cancers. LNCaP is also a human cell line that has been derived from prostatic 
cancer. NHE1 silencing was obtained in both the cell lines by transfecting them with 
NHE1 siRNA (Fig 4A and Fig 6A). Using etoposide and staurosporine as apoptotic 
triggers and β-Gal assay to assess cell survival, it was noted that decreased NHE1 
protein expression led to a significant increase in cell death in both U87 and LNCaP 
cells (Fig 4B and Fig 6B). To confirm apoptotic cell death, Caspase 3 assay was 
performed in U87 cells in order to delineate the type of cell death observed in these 
experiments. Caspase 3 is a downstream executioner caspase and has been classically 
used as a hallmark of apoptosis. Caspase 3 activity following incubation with 
etoposide was measured at different time points and it was observed that in NHE1 
silenced cells caspase 3 activity was higher at 4 and 8 hours as compared to control 
cells, but after prolonged incubation (i.e, 18 to 24 hours) this difference could not be 
seen (Fig 5). Same observation was made in LNCaP cells (Fig 7) except that 
staurosporine and etposide both triggers were used. Although the difference in 
caspase 3 activity between Control siRNA and NHE1 siRNA transfected cells is seen 
transiently, however the fact that NHE-1 silenced cells can activate caspase 3 earlier 








































































































































Figure 4. Silencing of NHE-1 gene leads to increased susceptibility to cell death 
in U87 cells. 
U87 cells were transfected with either Control  siRNA (Co) or NHE1 siRNA (NHE1). 
Twenty-four  hours post-silencing (A) western blot analysis was done and (B) cell 
death was triggered for 18 hours with either staurosporine (Sts) or etoposide (Eto) 
before being assessed using the  β-gal assay as described in Materials and Methods. 




























Figure 5. Time-dependent Caspase 3 (DEVDase) activity in NHE-1 silenced U87 
cells treated with etoposide. 
U87 cells were transfected with either Control  siRNA (Co) or NHE1 siRNA (NHE1). 
Twenty-four  hours post-silencing cell death was triggered with 10 or 20 μM of 
etoposide (Eto 10 and Eto 20). Lysates were prepared at different time points and 
DEVDase activity was measured. Results are shown as mean of 3 experiments + SE. 
* P < 0.02 ** P < 0.05 




























































Another explanation for marginal differences in caspase 3 activities could be due to 
low level of caspase activation in these experiments. 
Nevertheless, these results show that regulation of NHE-1 expression could be an 
important determinant of these cells’ sensitivity to apoptotic death. In summary, these 
experimental data confirm the role of NHE1 in resistance to cell death, and 
consequently when NHE1 gene is silenced leading to decreased NHE1 protein 
expression cells become more sensitized to apoptotic cell death. 
 
III.2.a Superoxide (O2.-) mediated cell survival is NHE-1-dependant 
Recent evidence has suggested that increased intracellular O2.- anion promotes cell 
survival (Clement MV and Stemenkovic I, 1996; Pervaiz S et al, 1999), whether 
achieved by its overproduction or due to inhibition of the O2.- scavanger enzyme 
Copper/Zinc Superoxide Dismutase (Cu/Zn SOD). SOD catalyzes the conversion of 
O2.- to 1hydrogen peroxide (H2O2). This enzyme scavenges O2.- radicals by catalyzing 






Diethyldithiocarbamate (DDC) is a selective inhibitor of Cu/Zn SOD. It has been used 
as an effective tool to increase intracellular O2.- levels by preventing its dismutation to 
H2O2 (Clement MV and Stemenkovic I, 1996). With the previous observations that 
O2.- acts as signal for cell survival and the results presented above we asked a simple 















































































































Figure 6. Silencing of NHE-1 gene leads to increased susceptibility to cell death 
in LNCaP cells. 
LNCaP cells were transfected with control (Co) or NHE1 siRNA (NHE1). Fourty-
eight hours post-silencing (A) western blot analysis was done and (B) cell death was 
triggered for 18 hours with either 0.5 μM staurosporine (Sts 0.5) or 20 μM etoposide 
(Eto 20) before being assessed using the  β-gal assay as described in Materials and 
















































































































































Figure 7. Caspase 3 (DEVDase) activity in NHE-1 silenced LNCaP cells upon 
treatment with etoposide and staurosporine. 
LNCaP cells were transfected with either Control (Co) or NHE1 siRNA (NHE1). 
Fourty-eight  hours post-silencing cell death was triggered with either 0.5 μM 
staurosporine (Sts 0.5) or 20 μM etoposide (Eto 20). Lysates were prepared at 4 (4H) 
and 8 hours (8H) and DEVDase activity was measured. Results show mean of 3 
experiments done in duplicate + SE. * P < 0.02 
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mediated inhibition of cell death. To test this hypothesis, NIH3T3 cells were 
transfected either with a control or NHE1 siRNA. Fig 8 is a control experiment to 
show that NHE-1 siRNA or cDNA transfection on its own doesn’t affect the 
intracellular O2.- levels. In NIH3T3 cells, twenty-four hours post transfection, serum 
was reduced to 0.5% for 24 hours prior to incubation with or without 1 mM DDC. In 
one set of cells 10% serum was added and O2.- levels were assessed and this was used 
as a positive control. As shown in Fig 9 DDC brings up O2.- in serum-starved cells 
almost up to the level comparable to cells grown in 10% serum. DDC was able to 
elicit an increase in intracellular O2.- levels in both control and NHE1 silenced cells, 
thus the ability of DDC to increase O2.- levels is independent of the level of NHE-1 
expression. After incubation with DDC for 10 hours, when cell death was induced 
using 0.5 μM staurosporine for 18 hours, it was observed that decreased NHE1 
expression prevented DDC mediated inhibition of staurosporine-induced cell death 
(Fig 10). In this set of experiments, crystal violet assay was used to assess cell death, 
as the transfection efficiency obtained with siRNA was routinely around 90%. 
To confirm that the type of cell death was apoptotic, Caspase 3 activity was assessed 
in the same experimental setting. Firstly caspase 3 activity was measured at 2, 4, 8 
and 12 hours time points. Staurosporine in the concentration of 0.5 µM does not kill 
NIH3T3 cells very quickly; rather there are around 30% viable cells even after 18 
hours incubation with staurosporine (Fig 10B). In NHE-1 silenced NIH3T3 cells 
caspase 3 activity was higher at 4 and 8 hour time points as compared to control cells, 































































Figure 8. Manipulation of NHE-1 expression does not affect intracellular 
superoxide levels. 
NIH3T3 cells were transfected with either pIRES, NHE1 cDNA (pECE-NHE1), 
control siRNA (Co sIRNA) or NHE1 siRNA. Forty eight hours post-transfection, 
intracellular superoxide levels were assessed by lucigenin assay as described in 
Materials and Methods. Results are shown as percent increase against non-transfected 


































































Figure 9. DDC leads to significant increase in intracellular superoxide levels in 
NIH3T3 cells. 
NIH3T3 cells were transfected with either control (Co) or NHE-1siRNA (NHE1) as 
described in Materials and Methods. Twenty-four hours post-transfection, NIH3T3 
cells were incubated in medium with 0.5% serum for another 24 hours prior 
incubation with or without 1mM DDC for 2 hours or with 10% serum, before 
measurement of intracellular superoxide. Superoxide level was assessed using 
lucigenein-based assay as described in Materials and Methods. Results show mean of 
3 experiments done in triplicate + SE. * P < 0.02 
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 On careful analysis of data in Fig 10D it can be seen that control cells treated with 
DDC show the lowest activation of caspase 3 and NHE-1 silenced cells without DDC 
treatment show the highest. 
Taken together, these data demonstrate that DDC mediated inhibition of 
staurosporine-induced cell death in NIH3T3 cells is dependent on NHE-1 protein 
expression. Interestingly, it can be noted in Fig 10A that DDC treatment for at least 
10 hours led to an increase in NHE1 protein expression, more so in control cells. Lack 
of this effect in NHE1-silenced cells can be due to the effectiveness of NHE1 siRNA 
in blocking translation of this protein. Thus, in summary, incubation of NIH3T3 cells 
with DDC resulted in an increased inhibition of cell response to death triggers that 
was dependent on NHE-1 expression. 
 
III.2.b Role of superoxide (O2.-) in NHE1-dependent cell survival in tumor cells 
Pro-oxidant state or increase in intracellular level of reactive oxygen species such as 
O2•- is a characteristic of tumor cells (Cerutti PA, 1985). To investigate the proposed 
role of O2.- in regulation of NHE-1, U87 cells were incubated either in 0.5% serum, 
10% serum or 0.5% serum plus diphenylene iodonium (DPI). DPI is an NADPH 
oxidase inhibitor and has been used widely to inhibit intracellular O2.- levels. As 
shown in Fig 11A treatment with 6 μM DPI for 24 hours inhibits serum-induced 
production of O2.-, and it even brings the level lower then serum-starved cells. Indeed, 
this can be explained on the basis that U87 cells are highly malignant and tumor cells 
usually display an altered redox status, and thus addition of DPI shows a significant 
drop in intracellular levels of O2.-. Interestingly and as expected, DPI- induced 















































































































































































































Figure 10. DDC-mediated inhibition of cell death is dependent on NHE-1 gene 










































































































































Figure 10. DDC-mediated inhibition of cell death is dependent on NHE-1 gene 
expression. 
NIH3T3 cells were transfected with either control (Co) or NHE-1siRNA (NHE1) as 
described in Materials and Methods. Twenty-four hours post-transfection, NIH3T3 
cells were incubated in medium with 0.5% serum for another 24 hours prior  
incubation with or without 1mM DDC for 10 hours before (A) Western blot analysis 
was done. 0.5 μM staurosporine (Sts) was then added for (B) 18 hours before being 
assessed for cell death. Cell death was assessed using crystal violet assay as described 
in Materials and methods. Cell death was calculated as (OD value of cells incubated 
with staurosporine / OD value of cells left for the same period of time without 
staurosporine). (C) Caspase assay was performed at 0, 2, 4, 8 and 12 hours after 
adding staurosporine. (D) Eight-hours time point was chosen for caspase 3 activity 
assays in subsequent experiments. Results show mean of 3 experiments done in 
duplicate + SE. * P < 0.02 
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(Fig 11B). Multiple bands seen in the western blot analysis of NHE-1 represent 
various levels of maturity of NHE-1 protein, as glycosylation is the major post-
translational modification that takes place as the NHE-1 protein migrates to the 
plasma membrane (Bullis et al, 2002). Fully glycosylated form of NHE-1 protein has 
a molecular weight of approximately 105 kD. 
To investigate further that the O2.--dependent increase in NHE1 expression leads to 
cell survival, U87 cells were either transfected with NHE1 cDNA or Control and 
NHE1 siRNA. As U87 cells growth rate is much faster as compared to NIH3T3 cells, 
all triggers had to be added 24 hours post-transfection in contrast to the usual 48 
hours, so that the cells didn’t become over-confluent. NHE1 protein was either over-
expressed or silenced using NHE1 cDNA and siRNA respectively to achieve varying  
levels of NHE1 protein expression. Twenty-four hours post transfection cells were 
treated with or without 6 μM DPI for 10 hours. Western blot analysis (Fig 12A) 
shows that a range of NHE1 expression was achieved across the spectrum of these 
transfection conditions. Addition of DPI reduced the level of expression of NHE1 in 
all transfection conditions, but less so in NHE-1 cDNA transfected cells (Fig 12A). In 
NHE-1 cDNA (pECE-NHE1) transfection, only endogenous level of NHE1 should be 
affected by incubation with DPI, as the transfected NHE-1 is under its own 
constitutive promoter control. Following the incubation with DPI, 20 μM etoposide 
was added to the cells to induce apoptosis. Caspase 3 activity was assessed after 8 
hours incubation with etoposide. Indeed it was noted that the lower the expression of 
NHE1 protein the higher was the caspase 3 activation (Fig 12B). 
It has been demonstrated that decreasing intracellular level of O2.- results in 
restoration of tumor cells’ sensitivity to cell death triggers (Pervaiz S and Clement 































































































































































































Figure 11. Inhibition of intracellular superoxide production prevents NHE-1 
protein expression in U87 cells. 
U87 cells were grown in RPMI medium containing 0.5%, 10% serum or 10% serum 
and 6 μM DPI (10% serum +DPI) for 24 hours before (A) intracellular superoxide 
level, and (B) NHE-1 protein level was assessed by western blot analysis. Intracellular 
O2•- is expressed as % of cell left in 0.5% serum (% control cells). For A the results 
shown are mean of 3 experiments done in duplicate + SE. For B the result shown is a 
representative experiment out of 2. * P < 0.02 
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regulation of NHE-1 expression correlated with an increase in sensitivity of U87 cells 
to etoposide induced cell death in a manner similar to that obtained upon silencing 
NHE-1 expression with NHE-1siRNA (see Fig 4B). These data suggest that the pro-
oxidant milieu of tumor cells (increase in constitutive levels of intracellular O2•-) 
maintains a level of NHE-1 gene expression that accounts for the resistance of cells to 
death stimuli. Caspase 3 activity in these experimental settings also correlated nicely 
with the expression level of NHE-1. It was observed that caspase 3 activation was 
higher in magnitude and occurred earlier in NHE1 silenced cells as compared to cells 
expressing normal or basal level of NHE1. 
Manipulation of NHE1 protein levels downstream of O2.--mediated NHE-1 gene 
activation was sufficient to alter U87 cells’ response to etoposide-induced cell death.  
Taken together data shown in Fig 11 supports that expression of NHE1 correlates 
with intracellular level of O2.-. Moreover results from Fig 10 and 12 shows that O2.- 
mediated inhibition of apoptotic cell death in NIH3T3 and U87 cells is dependent 
upon expression of NHE1. Hence, we next investigated the regulation of NHE1 
expression. 
 
III.3. NHE-1 gene expression is growth factor regulated 
NHE1 is activated by growth factors (Pouyssegur J, 1985), phorbol esters, and protein 
kinase C (PKC) (Mitsuka M and Berk BC, 1991). Increased mRNA levels of NHE1 
have been reported during cellular proliferation in intact tissues (Elsing C et al, 1994). 
Thus NHE1 is activated by a wide array of signals that cause cellular growth and 





































































































































Figure 12. Inhibition of intracellular superoxide production prevents NHE-1 
expression in U87 cells and increases their susceptibility to etoposide-induced cell 
death. 
NIH3T3 cells were either transfected with control siRNA (Co siRNA), NHE1 siRNA 
or pECE-NHE1 (NHE1 cDNA). Fourty-eight hours post-transfection cells were either 
treated with DPI (6 μM) or left in normal medium for 10 hours before (A) western 
blot analysis or (B) adding 20 μ M etoposide (Eto). Caspase 3 assay was performed at 
8 hours after adding etoposide. Results show mean of 3 experiments + SE. 
DPI= cells left in DPI alone; Eto= cells left in etoposide alone; DPI+Eto= cells pre-
incubated with DPI before adding etoposide. * P < 0.02 
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recently been studied. Recent cloning of NHE1 gene has permitted more in-depth 
study of promoter activity. Serum is an absolute requirement for cells growing in 
culture and it’s a well-documented activator of NHE1 gene expression (Besson P at 
al, 1998). 
“NIH3T3 1A8” and “NIH3T3 Luc” cell lines, which were obtained from Dr Larry 
Fleigel, have been stably transfected with a proximal 1.1 kb fragment of mouse NHE1 
promoter/enhancer upstream of a luciferase gene (Fig. 13). Thus, any signal that leads 
to increased NHE1 promoter activity would also result in increased luciferase enzyme 
production and this enzyme can be quantitatively measured by luciferase assay (as 
described in Materials and Methods). Both the cell lines were normally grown in 10% 
serum condition. Serum was withdrawn (i.e., cells were left in 0% serum and 0.5% 
serum) for 24 hours, a significantly higher NHE1 promoter activity was observed in 
those cells where serum was re-introduced for another 24 hours compared to those left 
throughout in 0% or 0.5% serum (Fig 14A). 0.5% serum was chosen for serum 
withdrawal conditions, as complete absence of serum would lead to complete cell 
cycle arrest and cell death over a prolonged incubation period. NIH3T3 1A8 cells 
were chosen for further study, as these cells showed better and more persistent results 
over the NIH3T3 Luc cells. 
PMA has been known to produce superoxide in the cell, which was also confirmed in 
the current experimental setting. PMA is also a well-documented signal for NHE1 
activity and expression. NIH3T3 1A8 cells were grown in 0% or 10% serum for 24 
hours before being subjected to PMA and EGF. Incidentally, in addition to the 
increase in NHE-1 promoter activity, the presence of serum is also a stimulus for 
intracellular generation of O2•- that could be inhibited by incubating cells with the 
oxidase inhibitor DPI. Interestingly, incubation of NIH3T3 1A8 cells with DPI also 
 66










Figure 13A. NIH3T3 1A8 cells stably transfected with proximal 1.1 kb fragment 
of NHE-1 promoter/enhancer upstream of a luciferase gene. 














































































































































































Figure 14. NHE-1 gene expression is growth factor regulated. 
(A) NIH3T3 1A8 (1A8) and NIH3T3 Luc (Luc) cells were grown in MEM medium 
supplemented with 10% FBS in 6-well plates to a 70% confluency. Cells were then 
left either in 10% serum, 0.5% serum or no serum with or without 100 nM phorbol 
12-myristate 13-acetate (PMA) for 24 hours. Cell lysates were prepared and 
Luciferase assay was performed as described in Materials and Methods. (B) NIH3T3 
1A8 cells left in either 10% serum or no serum were treated with either 100 nM 
phorbol 12-myristate 13-acetate (PMA), 6 uM diphenyleneiodonium (DPI), 100 ng/ml 
Epidermal growth factor (EGF), PMA+DPI or EGF+DPI for 24 hours. Cell lysates 
were prepared and Luciferase assay was performed. Results in both A and B show 

















































































































resulted in a significant inhibition of NHE-1 promoter activity (Fig 14B). In addition, 
PMA treatment in the presence of DPI did not show an increase in NHE1 promoter 
activity, again supporting the idea that O2•- is a signal for NHE1 gene transcription. 
On the contrary, DPI was unable to block the EGF-induced NHE-1 promoter 
activation. EGF might have an O2•--independent mechanism for NHE1 gene activation 
or it could be that it has multiple downstream pathways. 
 
III.4. Intracellular O2.- activates NHE-1 promoter activity 
A well-documented activator of NHE-1 gene expression is the presence of serum in 
the cell culture medium (Besson P et al, 1998). Indeed, mouse fibroblast NIH3T3 1A8 
grown in 10% serum showed higher NHE-1 promoter activity compared to the same 
cells grown in 0.5% serum for 18 hours (Fig 15A). Moreover, serum-dependent 
increase in NHE-1 promoter activity correlated with a higher level of NHE-1 protein 
compared to serum-starved cells (Fig 15B). As discussed previously, in addition to an 
increase in NHE-1 promoter activity, the presence of serum is also a stimulus for the 
intracellular generation of O2.- that could be partially inhibited by DPI (Fig 15C). 
Interestingly, incubation of NIH3T31A8 cells with DPI not only inhibited NHE-1 
promoter activity, but also decreased NHE-1 protein expression to the level of cells 
grown in 0.5% serum (Fig 15B). 
In order to confirm that O2•- could be an activator of NHE-1 gene expression, 
intracellular O2•- levels were manipulated in NIH3T3 1A8 cells and its effect on 
NHE1 promoter activation was studied. Increase in intracellular O2.- in NIH3T3 1A8 
cells was obtained either by pharmacological inhibition of Cu/Zn SOD with DDC or 






























Figure 15. Serum-induced activation of NHE-1 is dependant upon intracellular 
production of superoxide.  
NIH3T3 1A8 cells were grown in MEM medium containing 0.5%, 10% serum or 
10% serum and 6 µM DPI (10% serum +DPI) for 2 hours before C) level of O2•-, or 
24 hours before B) NHE-1 protein level, and A) NHE-1 promoter activity were 
measured as described in Materials and Methods. NHE-1 promoter activity and 
intracellular O2•- are expressed as % of cell left in 0.5% serum (% control cells). For B 
the result shown is a representative experiment out of 2. For A and C results are 


















































































































































































































superoxide in the cell through its redox cycling capability. Tiron was used as a 
selective O2.- scavenger. All these triggers were added in 0.5% serum condition in 
order to minimize the serum-induced production of O2.-. NHE1 promoter activity and 
protein expression were then assessed (Fig 17A and B). Interestingly, all conditions 
that led to an increase in intracellular O2.- also led to an increased NHE1 gene 
transcription. In addition and as expected, the protein expression of NHE-1 was also 
significantly increased under these experimental conditions (Fig 17B).  More 
importantly, pre-incubation of cells with the O2.- scavenger tiron reverted DDC-
induced increases in intracellular O2.-, NHE-1 promoter activity and protein 
expression (Fig 16, 17A and 17B). 
 
III.5.a Small GTPase Rac1-mediated survival is dependent upon NHE-1 protein 
expression 
In non-phagocytic cells, production of O2.- has long been attributed to mitochondrial 
respiration. However, during the 1990’s it became more and more evident that non-
phagocytic cells could also produce low levels of O2.- through mechanisms similar to 
the one described for phagocytes. In particular, Sudaresan et al. showed production of 
intracellular O2.- upon growth factor-mediated activation of the small GTPases Rac1 in 
fibroblasts (Sundaresan M et al, 1996). Moreover Irani et al. clearly demonstrated the 
role for Rac1-mediated O2.- production in cell cycle regulation in tumor cells (Irani K 
et al, 1997 and 1998). In order to study the role of Rac1 activation, and its 
downstream production of O2.-, in the induction of NHE-1 promoter activity, three cell 
























































































































































































Figure 16. Superoxide levels in NIH3T3 1A8 cells in response to different drugs. 
NIH3T3 1A8 cells were incubated with MEM medium containing 0.5% FBS in order 
to reduce the background level of O2•- seen in cells grown in serum.  Eighteen hours 
later either 250 uM paraquat, 1mM DDC, 1mM tiron or 1mM tiron plus 1mM DDC 
(Tiron+DDC) were added and O2•- level was assessed after 4 hours as described in 
Materials and Methods. In one set 10% serum was added and was used as a positive 
control. Results are shown as mean of at least 3 experiments done in duplicate + SE. * 


















































































































Figure 17. Superoxide is a signal for NHE-1 promoter activity. 
NIH3T3 1A8 cells were incubated with MEM medium containing 0.5% FBS. 
Eighteen hours later either 250 uM paraquat, 1mM DDC, 1mM tiron or 1mM tiron 
plus 1mM DDC (Tiron+DDC) were added and 18 hours later A) NHE-1 promoter 
activity and B) NHE-1 protein level was assessed. In one set 10% serum was added 
and was used as a positive control. For A results are shown as mean of at least 3 
experiments done in duplicate + SE. For B the result shown is a representative gel out 







































































































































































































































































MCT cells, stably transfected with the 1.1-kb proximal fragment of the mouse NHE1 
promoter/enhancer inserted 5′ to a luciferase gene (L6 1.1kb and MCT 1.1kb,) and 
NIH3T3 1A8 cells were transiently transfected with a constitutively active form of 
Rac1, RacV12. Luciferase activity of RacV12 transfected cells was compared to 
pIRES empty vector transfected cells. Indeed, a significant increase in NHE-1 
promoter activity was observed upon RacV12 transfection in all three cell types (Fig 
18A). Similar results where obtained with NIH3T3CatC2 and NIH3T3CatB3 cells 
(Fig 18B). These cell lines have been stably transfected with proximal 1.1 kb 
fragment of mouse NHE1 promoter upstream of a CAT sequence (these cells were 
also obtained from Dr Larry Fliegel). Reason for using these cells was to make sure 
that the effect that we see is due to direct activation of NHE1 promoter and not due to 
any direct effect on luciferase protein itself. Thus, CAT reporter assay was used to 
rule out the possibility of this artifact. Hence, data obtained with two different 
reporter genes in different cell lines support that activation of Rac1 stimulated NHE-1 
promoter activity. 
 
III.5.b Rac1-mediated NHE-1 protein expression is a function of its ability to 
produce superoxide  
Activation of Rac1, in addition to triggering intracellular production of O2.-, has also 
been shown to regulate actin polymerization and Jun kinase (JNK) activation 
(Campbell SL et al, 1998). In order to assess that Rac1-mediated induction of NHE-1 
gene promoter activity was a function of an increase in intracellular O2.-, NIH3T3 1A8 
cells were transfected with partial myc-tagged loss-of-function mutants of Rac1 
containing specific amino acid substitutions in the activated RacV12 background 


























































































































































Figure 18. Expression of RacV12 induces NHE-1 promoter activity in a variety 
of cells. 
A) MCT 1.1kb, L6 1.1kb and NIH3T3 1A8, and B) NIH3T3 CatB3 and NIH3T3 
CatC2 cells were transiently transfected with pIRESRacV12 (RacV12) or the empty 
pIRES vector control as described in Materials and Methods. Fourty-eight hours post-
transfection cells were serum deprived (0.5%serum) for 18 hours before A) luciferase 
activity or B) CAT expression were measured as described in Materials and Methods.  
Results are shown as mean of 3 independent transfections done in duplicate + SE. * P 
< 0.02 ** P < 0.05 
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inducing actin polymerization, whereas the RacV12H40 mutant induces actin 
polymerization but is defective in JNK activation. However, both of these mutations 
still retain the ability to generate intracellular O2.- (Joneson T and Bar-Sagi D, 1998). 
In contrast, the critical role of histidine 103 (H103) and lysine 166 (K166) of Rac1 
protein in O2.- production has been established (Toporik A et al, 1998). Thus, 
RacV12H103A and RacV12K166E mutants are deficient in O2.- production (Fig 19). 
This differential ability of the Rac mutants to produce O2.- in the cell was used to 
investigate whether NADPH interaction domain of Rac1 is important for its ability to 
induce NHE-1 gene activation. NIH3T3 1A8 cells were co-transfected with the 
pCMVβgal plasmid, which encodes for the β-galactosidase protein (β-gal) and either 
the pIRES control vector or pIRES-RacV12, pIRES-RacV12L37, pIRES-
RacV12H40, pIRES-RacV12H103A or pIRES-RacV12K166E. Fourty–eight hours 
post-transfection, cells were serum starved (0.5% serum) for 18 hours before 
assessing NHE-1 promoter activity. Cells were serum starved in order to prevent 
serum-induced activation of the promoter and background activity of the endogenous 
Rac. Co-transfection with the pCMVβgal plasmid was used to standardize 
transfection efficiency within the different constructs. It should be pointed out that the 
β−galactosidase activity for each transfection, and the level of expression of Rac 
mutants 48 hours post-transfection in NIH3T3 1A8 cells were not significantly 
different. Hence, the differences in the ability of different plasmids to induce NHE-1 
promoter activity could not be attributed to differences in protein expression. In 
addition, Fig 20A confirms that transient transfection of NIH3T3 1A8 cells with 
pIRESRacV12, pIRESRacV12L37, pIRESRacV12H40 induced a significant increase 
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Figure 19. Rac loss-of-function mutants. 
RacV12 and other Rac loss-of-function mutants have been cloned in pIRES 
expression vector. RacK166 and RacH103 are deficient in generating O2- in the cell. 

































Figure 20. NADPH oxidase interaction domain of Rac1 is required for Rac1-
induced NHE-1 promoter activity. 
NIH3T3 1A8 cells were transiently transfected with myc-tagged loss-of-function 
mutants of Rac1. Fourty-eight hours post-transfection A) cells were serum starved 
(0.5% serum) for 18 hours before production of O2- was measured as described in 
Materials and Methods. Results are expressed as % of O2- increased above cells 
transfected with the pIRES vector control (% of control) and B) cells were serum 
starved (0.5% serum) for 18 hours before NHE-1 promoter activity was measured as 
described in Materials and Methods. Results are shown as % of cells transfected with 
the pIRES vector control (% of control). Results are shown as mean of at least 3 














































































































































while a minimum induction was observed with pIRESRacV12H103A or 
pIRESRacV12K166E. Interestingly, Rac1-mediated production of intracellular O2.- 
correlated with the ability of Rac1 to increase NHE-1 promoter activity (Fig 20B). 
These results indicate that the effect of Rac1 on NHE-1 promoter activity and 
expression was not linked to JNK activation or actin polymerization. These findings, 
together with the results obtained with DDC and paraquat, strongly support that 
intracellular production of O2.- is responsible for Rac1-dependent increase in NHE-1 
promoter activity. 
Resistance to cell death in NIH3T3 cells also correlated with the ability of Rac1 to 
produce intracellular O2.-. Fig 21 shows the response of Rac mutants-transfected 
NIH3T3 cells to etoposide-induced killing. Indeed, previous work from our lab has 
shown that Rac expression plays an important role in inhibition of apoptosis to a 
variety of apoptotic signals. β-gal survival assay was used to assess cell death in this 
set of experiments. NIH3T3 cells over expressing pIRES-RacV12, pIRES-
RacV12H40 or pIRES-RacV12L37 were more resistant to cell death as compared to 
cells transfected with pIRES control vector or the Rac mutants deficient in O2.- 
production ( pIRES-RacV12H103A and pIRES-RacV12K166E). 
 
III.5.c Serum-induced NHE-1 expression might involve activation of Rac1  
Furthermore, we asked if serum-induced activation of NHE-1 promoter activity in 
NIH3T3 1A8 cells could be linked to activation of Rac1 through intracellular O2.- 
production. Serum induces intracellular production of O2.- and it also leads to 
activation of Rac1. In view of our previous findings that Rac1-induced O2.- production 






















































































































Figure 21. Rac1-mediated cell survival is dependant on its ability to produce 
superoxide. 
NIH3T3 1A8 cells were transiently transfected with myc-tagged loss-of-function 
mutants of Rac1. Fourty-eight hours post-transfection cells were incubated with or 
without etoposide for 18 hours and survival was assessed by β-Gal assay as described 
in Materials and Methods. Results are shown as % of cells transfected with the pIRES 
vector control (% of control). Results are shown as mean of at least 3 independent 
























Figure 22. Expression of RacN17 inhibits serum-induced NHE-1 promoter 
activity. 
NIH3T3 1A8 cells were transiently transfected with a control vector (pIRES) or a 
vector encoding a myc-tagged dominant negative form of Rac1 (pIRESRacN17). 
Fourty-eight hours post-transfection, cells were serum starved (0.5%serum) for 18 
hours before, serum was re-introduced to one set of cells for another 18 hours (A). (B) 
Expression of the myc-tagged RacN17 protein was detected by Western blot analysis 
as described in Materials and Methods. (C) Activation of NHE-1 promoter activity 
with serum in the presence (RacN17/serum) or absence of RacN17 (pIRES/serum). 
pIRES/no serum and RacN17/no serum represent transfected cells left in medium 
without serum. NHE-1 promoter activity was measured as described in Materials and 
Methods. Results are shown as Mean ± S.E of at least 3 independent transfections 










































































































require activation of Rac1 leading to increase in O2.- and consequently increased 
NHE-1 expression. 
NIH3T3 1A8 cells were transiently transfected with the dominant negative allele of 
Rac1, RacN17 and 48 hours post-transfection cells were serum starved for 18 hours 
before inducing NHE-1 promoter activity by adding 10% serum in the culture 
medium (Fig 22). Indeed, similar to the effect of DPI, expression of RacN17 inhibited 
serum-induced production of intracellular O2.- and NHE-1 promoter activity. These 
data further support a link between Rac1-induced intracellular O2.- production and 
NHE-1 promoter activity and gene expression, and suggest that Rac activity might be 
important in serum-mediated induction of NHE1 transcription. 
M14 human melanoma cells stably transfected with constitutively active form of Rac1 
(RacV12) and those transfected with the empty pIRES vector were used to further 
address the role of Rac1. Indeed, previous studies have demonstrated that 
M14RacV12 cells display decreased cell sensitivity to etoposide-induced death 
compared to cells expressing the pIRES vector control (Pervaiz S et al, 2001). 
However, upon silencing NHE-1 protein (Fig 23), cells’ sensitivity to etoposide in 
M14RacV12 cells was brought to the level of M14pIRES cells transfected with the 
control siRNA (Fig 24). Interestingly, down regulation of NHE-1 expression in 
M14pIRES cells further increased M14 cells’ sensitivity to etoposide-mediated death. 
These results are in agreement with the results obtained with over-expression or 
silencing of NHE-1 in NIH3T3 cells and support that increased NHE-1 protein level 
is involved in Rac1/O2.--mediated cell survival. Rac1-mediated production of 
intracellular O2.- always correlated with the ability of Rac1 to increase NHE-1 





















































































































































































Figure 23. Manipulation of NHE-1 protein expression in M14pIRES and 
M14pIRES-RacV12 cells by NHE-1 siRNA transfection. 
M14pIRES and M14RacV12 cells  were transfected with an NHE-1 specific siRNA 
(NHE-1 siRNA) or a control siRNA (co siRNA). Fourty-eight hours post-transfection, 
(A) Western blot analysis was done. (B) shows average band intensity of NHE-1/β 
actin. Result shown in A is a representative gel out of 3. B represent average of 3 







































































Figure 24. Rac-induced cell survival is dependant upon NHE-1 expression. 
M14pIRES and M14RacV12 cells were transfected with either control (Co siRNA) or 
NHE1 siRNA and 0.5µg pCMV-βgal as described in Materials and Methods. Fourty-
eight hours post-transfection, cell death was induced with 40 µM etoposide for 18 
hours before being assessed by β-gal assay. Control cells represent M14pIRES cells 
transfected with the control siRNA. Cell death was determined by the -Gal assay as 
described in Materials and Methods. Results are shown as Mean ± S.E of at least 3 
independent transfections done in duplicate. * P < 0.02 
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findings, together with the results obtained with DDC, strongly support that activation 
of NHE-1 gene promoter is a critical target for O2.--mediated survival. 
 
III.6. H2O2 inhibits NHE-1 promoter activity 
The intracellular concentration of O2.- in eukaryotic cells is tightly regulated by the 
activity of the enzyme Cu/Zn SOD, which catalyzes the dismutation of O2.- to H2O2 
and O2. Therefore the first question that comes to mind is that whether the increase in 
NHE-1 promoter activity was a direct effect of O2.- on NHE-1 gene transcription or a 
result of H2O2 production leading to H2O2-dependent transcription of the NHE-1 
gene. It was also important to rule this possibility out as redox-regulated transcription 
factors like NFκB and AP-1 have been shown to be activated by H2O2 (Bowie A and 
O’Neil LA, 2000). To test that, NIH3T3 1A8, cells were incubated with increasing 
concentrations of H2O2 for 18H before the activity of NHE-1 promoter was assessed. 
It should be pointed out that the concentration of H2O2 used throughout this study was 
≤150μM because higher concentrations elicited cytotoxicity. Interestingly, in 
complete contrast to the stimulatory effect of O2.-, results clearly showed a 
concentration dependent repression of NHE-1 promoter activity by H2O2 (Fig 25A). 
These results were corroborated by western blot analysis of NHE-1 protein in lysates 
obtained from NIH3T3 1A8 cells treated for 18H with H2O2 (Fig 25C). Similar results 
were obtained with NIH3T3 CatC2 and NIH3T3 CatB3 (two different clones of 
NIH3T3 cells stably transfected with a 1.1-kb proximal fragment of the mouse NHE1 
promoter/enhancer inserted 5′ to the chloremphenicol acetyl transferase (CAT) gene) 
(Besson P et al, 1998) (Fig 25B). Non-toxic concentration of H2O2 did not activate the 
NHE-1 promoter. Instead, incubation of all three cell lines with increasing  
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Figure 25. H2O2 inhibits NHE-1 promoter activity in NIH3T3 cells. 
A) NIH3T3 1A8, B) NIH3T3CatB3 and NIH3T3CatC2 cells were incubated with 
increasing concentrations of H2O2 for 18 hours before the NHE-1 promoter activity 
was measured by either A) the luciferase assay or B) detection of the CAT protein as 
described in Materials and Methods. C) shows western blot analysis of NIH3T3 1A8. 
Gel in C) is a representative gel out of 3. Results are shown as mean of at least 3 
experiments done in duplicate ± S.E. * P < 0.02 
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concentration of H2O2 resulted in inhibition of NHE-1 promoter activity. Taken 
together, these data provide strong evidence to support that the expression of NHE-1 
is redox regulated, with distinctly opposing effects of O2.- and H2O2 on its promoter 
activity and protein expression. Moreover, the use of two different reporter gene rules 
out the possibility that the observed inhibitory effect on NHE-1 promoter activity 
could have been attributed to the inhibitory effect of H2O2 on the reporter gene 
(luciferase or CAT) itself.  
In addition, results showing that incubation with DDC resulted in a significant 
activation of the promoter also favor O2.- rather than H2O2 in the activation of the 
NHE-1 gene transcription, as DDC inhibits Cu/Zn SOD and prevents dismutation of 
O2.- to H2O2. 
 
III.7. H2O2 leads to decreased NHE-1 expression and increased susceptibility to 
cell death 
With the data obtained from previous experiments, it was becoming increasingly 
evident that level of expression of NHE1 protein was of critical importance in 
determining a cells’ response to death triggers. Thus, H2O2-mediated repression of 
NHE1 promoter and decreased protein expression should have the same effect. 
Interestingly and as expected, similar to the result obtained by silencing NHE-1, pre-
incubation of NIH3T3 cells with 50 and 100 μM H2O2 for 18hours sensitized NIH3T3 
cells to etoposide-induced cell death (Fig 26). As is clearly evident in the figure, H2O2 
on its own did not cause cell death but its presence enhanced etoposide-induced cell 
death in NIH3T3 cells. It can be deduced that a decrease in NHE1 protein expression, 
independent of whether achieved by gene silencing, incubation with DPI or H2O2 has 



















































Figure 26. H2O2 treatment of NIH3T3 cells results in increased susceptibility to 
etoposide-induced killing. 
NIH3T3 cells were incubated for 18hours with 50 or 100 µM H2O2  before cell death 
was triggered with 20 (Eto 20µM) or 40 µM etoposide (Eto 40µM). Control 
represents cells left in normal medium. Cell viability was assessed using the crystal 
violet assay and result is shown as OD at 595nm. Results are shown as mean of at 






Most studies on NHE1 have been focused on the regulation of its activity. The data 
presented here addresses a potentially very important mechanism of its gene 
regulation. 
The data presented until now clearly shows that NHE1 gene is redox regulated, being 
upregulated by increased O2.- in the cell and repressed by H2O2. And that this gene 
regulation translates well into protein expression and affects cells’ response to death 
triggers. These finding were tested across a wide range of murine and human cell 
lines. As discussed earlier, a pro-oxidant intracellular milieu confers a permissive 
environment for the growth and proliferation of the cells. Regulation of NHE1 by O2.- 
could now be proposed as a mechanism underlying this pro-oxidant state that leads to 
tumor cell survival. 
 
III.8. Regulation of intracellular pH as one of the mechanisms of NHE-1-
mediated cell survival 
The predominant cellular function of NHE-1 is the regulation of intracellular pH 
(pHi). In addition to protecting cells from intracellular acidification, NHE has also 
been shown to initiate shifts in pHi that stimulate growth of cells and plays a role in 
malignant transformation (Reshkin SJ et al, 2000). However, it is widely accepted that 
at physiological pHi the exchanger is virtually in a quiescent state in unstimulated 
cells. Hence, increase in NHE-1 protein level in NIH3T3 may not be expected to 
significantly affect steady state pHi. Indeed, over-expression of NHE-1 in NIH3T3 
cells transiently transfected with 5μg of pECE-NHE1 resulted in 40% increase in 
NHE-1 protein level (see Fig 1A), but had a very minimal effect on pHi (from 
7.22±0.01 in the vector control transfected cells to 7.29±0.01 in cells over-expressing 









Figure 27. Increased NHE1 protein expression level leads to a minimal increase 
in pHi. 
NIH3T3 cells were transfected with increasing concentrations of the pECE vector 
encoding for the human NHE-1 cDNA, and empty vector pIRES was added 
corresponding to varying pECE-NHE1 cDNA in order to keep the total cDNA amount 
constant. Fourty-eight hours post transfection intracellular pH was measured using 
BCECF assay as described in Materials and Methods. Results are shown as mean of at 









Figure 28. Silencing of NHE1 gene results in a minimal decrease in intracellular 
pH in NIH3T3 cells. 
NIH3T3 cells were either transfected with NHE1 siRNA or control siRNA (Co 
siRNA). Fourty-eight hours post transfection intracellular pH was measured using 
BCECF assay. Results are shown as mean of at least 3 experiments done in duplicate 
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On the contrary, upon silencing of NHE-1 gene, a drop in intracellular pH was 
observed but again, the difference was very subtle with ∆pH value of only 0.07 units 
(Fig 28). Upon transfection of NIH3T3 cells with RacV12 and other Rac-loss-of- 
function mutants, the effect of these mutants on the NHE-1 promoter and O2.- 
inducing activity (see Fig 21) correlated with their effect on cytoslic pH; RacV12, 
RacH40 and RacL37 induced cytosolic alkalinization, whereas the two mutants 
lacking O2.- inducing activity of Rac1 (RacK166 and RacH103) failed to alter 
cytosolic pH (Figure 29). 
On the other hand, when M14pIRES and M14RacV12 cells were transfected with 
NHE1 siRNA, there was a significant difference in terms of ∆pH value. As shown in 
Fig 30, the resting pHi values differ among M14pIRES and M14RacV12, with the 
later having a higher pHi value. Interestingly, different NHE-1 expression levels in 
M14 cells resulted in significant differences in pHi. For example, the ∆pH between 
M14pIRES transfected with control siRNA and M14pIRES cells transfected with 
NHE1 siRNA was 0.25 units (Fig 30). 
As discussed earlier, malignant gliomas are comprised of highly proliferating cancer 
cells, and exhibit increased glucose uptake and anaerobic glycolysis. Increased 
production of lactic acid leads to increased generation of H+. Studies have indicated 
that malignant gliomas display a higher pH as compared to non-transformed 
astrocytes and this alkaline pHi has been attributed to the increased activity of NHE1 
(Lee AM et al, 2000). Indeed, in U87 cells, comparing Co siRNA and NHE1 siRNA 
transfected cells, there was a significant decrease in resting pHi, ∆pH of 0.27 units 
(Fig 31A). Upon exposure of cells to an acid load and then looking at the pHi 
recovery in a bicarbonate-free buffer, it could be confirmed that in NHE1-silenced 
increase in NHE-1 protein seems unlikely to play a critical role in regulating steady 
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state pHi in rmal cells. NHE-1 pump activity rather then expression seems to be 
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Figure 29. Increase in intracellular pH correlates with the ability of Rac mutants 
to produce superoxide and induce NHE1 transcription. 
NIH3T3 cells were transiently transfected with myc-tagged loss-of-function mutants 
of Rac1. Fourty-eight hours post-transfection measurment of intracellular pH was 
done using BCECF assay as decribed in Materials and Methods. Results are shown as 










Figure 30. Silencing of NHE1 gene results in a drop in intracellular pH in 
M14pIRES and M14RacV12 cells. 
M14pIRES and M14RacV12 cells were either transfected with NHE1 siRNA or Co 
siRNA. Fourty-eight hours post transfection intracellular pH was measured using 
BCECF assay. Results are shown as mean of at least 3 experiments done in duplicate 















































































Figure 31A. Silencing of NHE1 gene results in a drop in intracellular pH in U87 
cells. 
U87 cells were either transfected with NHE1 siRNA or Co siRNA. Twenty-four hours 
post transfection intracellular pH was measured using BCECF assay. Results are 








































Figure 31B. Decreased expression of NHE1 leads to decreased activity of the 
pump in U87 cells. 
U87 cells were either transfected with NHE1 siRNA or Co siRNA. Twenty-four hours 
post transfection intracellular pH recovery assay was performed as described in 
Materials and Methods. Results show mean of 2 experiments done in triplicate. 
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U87 cells there was a blunted recovery phase (Fig 31B) as compared to the control 
cells.  
Hence, taken together the data from NIH3T3, M14 and U87 cells, O2.--mediated state 
pHi in normal cells. NHE-1 pump activity rather then expression seems to be 
responsible for the pHi modulating function of this protein. 
Pharmacological inhibition of NHE1 activity has been achieved with the diuretic 
amiloride and its derivatives. Although the exact mechanism is not yet known, NHE1 
inhibitors are thought to act by competitively inhibiting Na+ binding at the 
extracellular cation-binding site (Putney LK et al, 2000). Indeed, transient transfection 
of NIH3T3 cells with RacV12 resulted in an increase in pHi that could be reverted by 
incubation with amiloride (Figure 32). Similar results were obtained with M14 cells. 
M14RacV12 cells had a higher resting pHi than the vector transfected cells that could 
be reverted following inhibition of NHE-1 activity with amiloride (Figure 33). These 
data indicate that the increase in resting pHi induced upon transfection (of NIH3T3 
cells or M14 melanoma cells) with RacV12 is dependent on the activity of the NHE-1 
exchanger. 
 
III.9. Region of NHE-1 promoter involved in O2.--mediated activation 
Some preliminary work was done in order to delineate the region of NHE1 promoter 
that responds to O2.--mediated activation. L6 rat myoblasts stably transfected with 
different truncated versions of NHE-1 promoter/enhancer upstream of a luciferase 
gene were used (Yang W et al, 1996). These cells were also obtained from Dr Larry 
Fliegel’s lab. Fig 34A shows a schematic diagram of the constructs used for 







































Fig 32. Increased intracellular pH in RacV12 over-expressing NIH3T3 cells is 
dependent upon NHE1 activity.  
NIH3T3 cells were transiently transfected with pIRESRacV12 or empty vaector 
pIRES. Fourty-eight hours post-transfection A) cells were treated with or without 500 
uM Amiloride for another 24 hours. Intracellular pH was measured by BCECF assay. 
Results are shown as mean of at least 3 independent transfections done in duplicate ± 






































Fig 33. Increased intracellular pH in M14 cells is a function of NHE1 activity. 
M14pIRES and M14RacV12 cells were grown with or without Amiloride (500 uM) 
for 24 hours before intracellular pH was measured using BCECF assay. Results are 































D C B A Human NHE1
D = -237 to -216 
C = -124 to -111
B = -108 to -65
A = -31 to -11
Strong homology (>90%) 
between human and mouse NHE1
Human NHE1 gene is located on 
chromosome 1, spans approx. 70 kb, and 


















Figure 34. NHE-1 promoter/enhancer constructs. 
(A) Different length truncated NHE-1 promoter constructs stably transfected into L6 
cells. (B) Comparison of mouse and human NHE-1 promoter. 
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-155, and -125 respectively for pXP-0.9MP, pXP-0.5MP, pXP-0.2MP, pXP-0.l8MP, 
and pMP +AP2. 
Yang et al have demonstrated that deletion of the promoter up to and including the 
AP2 site resulted in almost total elimination of activity. Inclusion of the AP2 site (-
125) resulted in a significant increase in activity of the promoter. Inclusion of base 
pairs - 155 to - 126 (pXP-0.18MP plasmid) resulted in a small insignificant increase 
in the activity of the promoter. However inclusion of 16 more base pairs including a 
pyrimidine rich region resulted in a large, significant increase in activity of the 
promoter. Inclusion of up to the entire 8.5 kb region of the NHEl promoter did not 
result in further significant increases in activity of the promoter (Yang W et al, 1996). 
Thus, AP2 binding site and the pyrimidine-rich region of mouse promoter have been 
shown to play a significant role in gene regulation. Using DNA footprinting 
experiments Kolyada et al have suggested that there are 4 regions of the human NHEl 
promoter (A-D) that may be important in NHEl expression (Kolyada AY et al, 1994). 
Comparison of these regions in human NHE-1 to mouse NHE1 promoter is shown in 
Fig 34B.  
As we were interested in narrowing down the region of NHE-1 promoter that 
responds to O2.--mediated activation, L6 cells were incubated with herbicide paraquat 
to increase intracellular O2.- levels. First a non-toxic dose of paraquat was determined 
that led to a significant rise in intracellular levels of O2.- (Fig 35).  
When L6/1.1kb, L6/0.9kb, L6/0.5kb, L6/0.2kb and L6/0.18kb were incubated with 
125 μM paraquat, it lead to an increase in intracellular O2.- levels (Fig 36A). When 
NHE-1 promoter activity was measured in these cells, it was noted that L6 cells 
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Figure 35. Low dose of paraquat leads to increased superoxide production in L6 
cells. 
L6/1.1kb cells were incubated with varying concentrations of herbicide paraquat for 4 
hours. Lucigenin assay was performed as described in Materials and Methods. Results 









































































Figure 36. Superoxide-mediated NHE1 gene transcription in L6 cells. 
L6/1.1, L6/0.9, L6/0.5, L6/0.2 and L6/0.18kb cells were incubated with 0.125 mM 
paraquat. (A) Lucigenin assay was performed 2 hours after addition of paraquat and 
(B) Luciferase assay was performed at 10 hours as described in Materials and 









































































































































increrase in promoter activity, while further reduction of promoter length resulted in 
low or no response (Fig 36B).   
To confirm these findings, L6/1.1kb, L6/0.5kb, L6/0.18kb and L6/AP2+ cells were 
transfected either with pIRESRacV12 or empty pIRES vector (Fig 37). Fourty eight 
hours post-transfection, NHE-1 promoter activity was measured and interestingly it 
complemented the data obtained with paraquat treatment of L6 cells. Thus we can 
conclude here that O2.--mediated activation of NHE-1 promoter lies upstream than the 
AP2-binding site, and somewhere between the 0.18kb and 0.5kb region of the 
promoter. However these data are preliminary results that require extensive research 
work in order to narrow down the O2.--responsive element on NHE-1 promoter or 





























Figure 37. Rac1-induced transcription of NHE-1 is not seen below 0.5 kb in L6 
cells. 
L6/1.1, L6/0.5, L6/0.18 and L6AP2+ cells were transiently transfected with pIRES 
empty vector or pIRESRacV12 cDNA. Fourty eight hours post-transfection, 
luciferase assay was performed as mentioned in Materials and Methods. Results are 
shown as percentage increase in luciferase activity in RacV12 transfected cells against 
the pIRES vector transfected cells. Results are shown as Mean ± S.E of at least 3 



































































Discussion and conclusions 
 
IV.1. How tumors develop 
Normal tissue homeostasis requires the physiological deletion of cells by process of 
apoptosis, a genetically determined programmed cell death (Kerr JF et al, 1972). 
Taken together, apoptotic processes are of widespread biological significance, being 
involved in development, differentiation, proliferation/homoeostasis, regulation and 
function of the immune system and in the removal of defective and therefore harmful 
cells. Thus, deregulation of the apoptotic program is implicated in a variety of 
pathological conditions: defects in apoptosis can result in cancer, autoimmune 
diseases and spreading of viral infections; while on the other hand neurodegenerative 
disorders, AIDS and ischaemic diseases are caused or enhanced by excessive 
apoptosis (Fadeel et al., 1999).  
Tumors arise because the homeostatic control mechanisms that maintain the 
appropriate number of cells in normal tissues is defective, leading to an imbalance 
between cell proliferation and cell death. This leads to an uncontrolled expansion of 
the cell population. Thus, one of the major challenges cancer research has faced in 
past decades has been to devise ways to induce apoptosis in tumor cells or make them 
more sensitive to apoptotic triggers. 
 
IV.2. Permissive intracellular milieu 
One of the mechanisms through which cancer cells evade death signals and proliferate 
unchecked is by maintaining a permissive intracellular environment. Slightly pro-
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oxidant intracellular milieu is a characteristic many tumors share and it has been 
proposed to promote cell growth and inhibit cell death. It is established that a pro-
oxidant state where intracellular concentrations of activated forms of oxygen are 
increased can modulate expression of early growth-related genes, leading in some 
cases to aberrant cell growth and differentiation (Burdon et al., 1995). Indeed, 
increased metabolic rate and ROS production in tumor cells may provide them with a 
survival advantage over their normal counterparts (Cerutti PA, 1985). The field of 
ROS research has witnessed a revolution of ideas. Highly reactive and damaging ROS 
are now thought to play a role in a variety of physiological functions (Finkel T, 1998 
and 2000). Interestingly, the regulation of tumor cells’ sensitivity to death stimuli has 
been shown to be linked to the intracellular levels of O2.- and H2O2  (Pervaiz S and 
Clement MV, 2002 and 2004; Clement MV and Pervaiz S, 1999 and 2001). 
Classically, the role of ROS in inducing necrotic cell death is well accepted, however 
the role of ROS in apoptosis is more controversial. Though a fair amount of 
controversy exists with respect to the precise pro- or anti-apoptotic functions of O2.- 
and H2O2, some inducers of apoptosis stimulate intracellular production of H2O2, and 
many inhibitors of apoptosis have antioxidant properties or enhance the cellular 
antioxidant defense mechanism. These observations have led to the suggestion that 
ROS are effectors for a variety of triggers of apoptosis (Clement MV and Pervaiz S, 
2001). 
 
IV.3. Alkaline pHi and role of NHE-1 
In addition to a pro-oxidant state, tumor cells also display altered intracellular pH 
(pHi) regulation. Maintenance of intracellular pH within a very tight range is 
important for most if not all physiological functions. It has been shown that cellular 
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pH is crucial for biological functions such as cell proliferation, invasion and 
metastasis, drug resistance and apoptosis. Intracellular acidification has been shown to 
be a trigger in the early phase of apoptosis and leads to activation of endonucleases 
inducing DNA fragmentation. To avoid intracellular acidification under such 
conditions, pH regulators are thought to be up-regulated in tumour cells. Indeed, it 
was recently demonstrated that pre-treating tumor cells with proton pump inhibitors 
(PPIs) significantly increased their sensitivity to killing by conventional 
chemotherapeutic drugs (Francesca et al., 2004). It has been proposed that regulation 
of intracellular pH may be a possible mechanism for tumour-selective therapy 
(Raghunand et al., 1999; Wong P et al, 2002; Wahl ML et al, 2002). The past decade 
has also seen the discovery of the physiological mechanism by which a decrease in 
intracellular pH is the initial trigger for a cascade of events resulting in apoptosis. 
Multiple Drug Resistance (MDR) phenotype of tumor cells has also been linked to an 
alkaline pHi in tumor cells (Keizer HG and Joenje H, 1989; Weinsburg JH et al, 
1999). 
The ubiquitously expressed Na+-H+ exchanger NHE-1 is one of several ion 
exchangers involved in pHi homeostasis. Although NHE-1’s role in tumorigenesis has 
been long known, but recent advances in molecular understanding of its functions and 
cloning of NHE-1 gene has shed a new light on this potentially very important 
subject. Evidence strongly suggests that, in addition to regulating pHi NHE-1 could 
be a critical regulator of cell sensitivity to death stimuli (Wu KL et al, 2003) and that 
this ability of NHE-1 may go well beyond its primary function of pHi homeostasis. 
NHE-1 has also been shown not only to facilitate tumor development but also to 
maintain tumorigenic phenotype (Reshkin SJ et al, 2000). 
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IV.4. Regulation of NHE-1 
NHE-1 could be regulated at multiple levels. Although the increase in transport 
activity of NHE-1 is often associated with phosphorylation of a number of serine 
residues within the distal C-terminal cytoplasmic domain of the NHE-1 protein, there 
is strong evidence that NHE-1 activity is regulated by phosphorylation dependent as 
well as independent mechanisms (Putney LK et al, 2002). Many transcription factors 
that are important during cell development and differentiation have also been shown 
to activate NHE1 gene. Evidence suggests that NHE1 activation at both transcription 
and protein level plays an important role in regulating its function. Mitogenic 
stimulation of NHE1 leads to increased gene transcription and increased expression of 
NHE1 protein on cell surface (Besson P et al, 1998). Furthermore, there is evidence to 
support that mRNA levels of the exchanger are increased during cellular proliferation 
in intact tissues (Elsing C et al, 1994). 
 
IV.5. Rationale of our study 
Transcription of NHE-1 could be increased by a variety of stimuli, such as serum, 
acidosis, PKC and cell proliferation (Besson P et al, 1998; Putney LK et al, 2002); 
however the signals involved in NHE-1 gene transcription remain largely unknown. It 
is really intriguing to note that a slight pro-oxidant intracellular environment also 
shares the pro-survival and proliferative properties of NHE-1. Indeed it has been 
recently demonstrated that cellular redox status is important in maintaining an 
alkaline pHi (Pervaiz S and Clement M V, 2002a). In addition, the link between 
intracellular ROS and NHE-1 is supported by the observations that the 
aforementioned inducers of NHE-1 gene expression have also been implicated in 
intracellular ROS production. Intrigued by these findings, we set out to investigate 
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whether their exists a true cause-and-effect relationship between the pro-survival 
activity of O2.- and NHE-1. 
 
IV.6. Regulation of NHE-1 gene expression regulates cells’ response to death 
triggers 
It has been shown that mitogenic stimulation of NHE1 leads to increased gene 
transcription and increased expression of NHE1 protein on cell surface (Besson P et 
al, 1998). Therefore we first asked if regulation of NHE-1 gene expression affected 
cell sensitivity to apoptosis. We show clearly that level of NHE-1 gene expression 
regulates the sensitivity of mouse fibroblast NIH3T3 cells, the human glioma U87 
cells and the human melanoma M14 cells, to etoposide- or staurosporine-induced cell 
death. NHE-1 was either over-expressed in these cells or silenced by using a specific 
siRNA, and a range of protein expression level was achieved. Cell death assessment 
in these experiments was done using the β-gal assay as described in Materials and 
Methods and reported previously (Pervaiz S et al, 2001). This method was used 
because it allows for the measurement of cell death in transfected cells only. This 
approach is particularly important when over-expressing NHE-1 keeping in view the 
transfection efficiency of ~30% usually obtained in these experiments. Hence, 
measurement of cell death in β-gal transfected cells is a better index of the effect of 
NHE-1 over-expression on cells’ response to death triggers. On the contrary 
transfection of cells with the specific NHE-1 siRNA routinely affects 90% of the 
cells. However, in order to compare results obtained by over-expression or down-
regulation of NHE-1 protein the β-gal assay was also used when assessing NIH3T3 
cells’ response to staurosporine-induced cell death upon silencing of the NHE-1 gene 
expression. Hence, taken together, these data show that staurosporine can either 
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induce 15% or 48% death in NIH3T3 cells depending on the level of NHE-1 
expression (Fig 3). 
Gliomas and malignant melanomas are amongst the most aggressive human cancers. 
By using U87 and M14 cells, it was very encouraging to observe that by silencing the 
NHE-1 gene, there was a significant increase in their sensitivity to death triggers like 
staurosporine and etoposide. To confirm that death induced by etoposide and 
staurosporine was apoptotic in nature, caspase 3 activity was measured. It was noted 
that in NHE-1 silenced cells caspase 3 activation was induced earlier and the 
magnitude was higher as compared to control cells. Although, this difference in 
caspase activity was abrogated when cells were incubated with etoposide or 
staurosporine for longer duration (i.e; 18-24 hours). The fact that there was a 
difference in the pattern of initial activation of caspase 3 makes more sense in 
physiological terms, as prolonged incubation with cytotoxic drugs will ultimately 
induce apoptosis or even necrosis. An ideal scenario is where lower doses of cytotoxic 
drugs would effectively kill tumor cells leaving normal cells virtually unharmed. 
The relative differences observed in caspase activities were not very marked. This 
could be due to low level of caspase activation, or even some component of caspase-
independent cell death. Despite a low level of caspase activation, differences in 
magnitude of cell death sensitivity between control and NHE1-silenced cells were 
significantly marked. Interestingly, a recent study has reported caspase-independent 
paraptosis like mode of cell death following NHE-1 inhibition (Schneider D et al, 
2004). In summary, by manipulating the protein expression of NHE-1, we were able 
to alter cells’ sensitivity to apoptotic triggers. 
 
IV.7. Superoxide (O2.-) mediated cell survival is NHE-1-dependant 
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As described earlier, there is evidence to suggest that transformation and proliferation 
are favored during intracellular redox imbalance leading to a pro-oxidant intracellular 
milieu (Cerutti PA, 1985). The effect of O2.- on NHE-1-dependent survival was 
assessed by several experiments. Hence, to test if an increase in NHE-1 expression 
could be the mechanism involved in O2.--mediated survival, we tested the effect of 
NHE-1 gene silencing with a specific NHE-1 siRNA on the ability of DDC to 
increase intracellular O2.- and inhibit cell death induced by exposure to staurosporine. 
Silencing of NHE-1 gene expression did not prevent DDC-induced increase in 
intracellular level of O2.- in NIH3T3 cells, however, NHE-1siRNA prevented DDC-
mediated inhibition of staurosporine-induced cell death. Secondly, serum-induced 
NHE-1 protein expression was partially inhibited by the widely used oxidase 
inhibitor, DPI; incubation of serum induced U87 cells with DPI resulted in inhibition 
of intracellular O2.- production and prevented the increase in NHE-1 protein synthesis. 
Taken together, these findings suggest that, in addition to activation of the exchanger 
leading to alkaline pHi, redox regulation of NHE-1 gene expression could be critical 
in tumor cell formation. In particular, resistance of tumor cells to death triggers due to 
a slight increase in intracellular O2.- could be linked to the regulation of NHE-1 
protein expression. 
 
IV.8. NHE-1 gene expression is growth factor regulated 
NHE-1 is activated by a wide variety of signals that promote cellular growth and 
proliferation. A well-documented activator of NHE-1 gene expression is the presence 
of serum in the cell culture medium (Besson P et al, 1998). Tumor cells usually are 
not dependent on growth factor stimulation and in cell culture are relatively 
independent to serum supplementation, while normal cells would die if not supplied 
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with serum. Activation of survival pathways in tumor cells are achieved by growth 
factor-independent pathways. The fact that NHE-1 is over-expressed and shows 
higher activity in tumor cells indicates an alternative pathway. Indeed the results 
obtained with dominant negative Rac1 (RacN17) indicate that serum-induced NHE-1 
promoter activation is, at least in part, dependent on activation of Rac1 (discussed in 
detail later). Thus, activated Rac in tumor cells might act as a substitute to 
serum/growth factors. 
 
IV.9. Intracellular O2.- activates NHE-1 promoter activity 
Mouse fibroblast NIH3T3 cells, stably transfected with the 1.1-kb proximal fragment 
of the mouse NHE1 promoter/enhancer inserted 5’to a luciferase gene (NIH3T3 1A8) 
(Besson P et al, 1998) were used to study the effect of serum and various drugs on 
NHE-1 promoter. In addition to NHE-1 promoter activation, serum is also known to 
produce superoxide in the cell. Indeed, generation of O2.- could be partially inhibited 
by incubating cells with the widely used oxidase inhibitor DPI. Interestingly, 
incubation of NIH3T3 1A8 cells with DPI also resulted in the inhibition of NHE-1 
promoter activity and decrease in NHE-1 protein expression to the level of cells 
grown in 0.5% serum. DDC-induced activation of NHE-1 promoter in the absence of 
serum also provides evidence in favor of O2.- being an activator of NHE-1 gene 
expression. In addition, pre-incubation of cells with the O2.- scavenger tiron reverted 
DDC-induced increases in intracellular O2.-, NHE-1 promoter activity and protein 
expression. Taken together these results strongly support a role for O2.- production as 
a signaling molecule for NHE-1 gene expression, and show that serum-induced 
activation of NHE-1 involves O2.-. Moreover, as discussed previously, tumors display 
a pro-oxidant intracellular environment, it is very intriguing to note that a slight 
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increase in intracellular O2.- levels can lead to an increased firing of NHE-1 promoter 
and subsequently increased protein expression. As tumor cells display a chronic and 
persistent phase of proliferation and inhibition of cell death signals, it seems 
imperative that NHE1 has to be regulated on long-term basis if it were to confer the 
cells with a survival advantage. Thus a scenario of increased intracellular O2.- leading 
to a persistently increased baseline expression of NHE-1 in tumor cells could explain, 
in part, the inherent ability of these cells to resist normal apoptotic triggers. 
 
IV.10. Small GTPase Rac1-mediated survival is dependent upon NHE-1 protein 
expression 
Mutated Ras is an oncogene found in many human cancers. Rac is an important 
downstream target of Ras which has multiple functions in the cell. Interestingly, 
mitogenic signal triggered by the oncogene Ras in a fibroblast cell line has been 
attributed to Rac-dependent intracellular production of O2.-, thereby, once again 
lending support to the hypothesis that O2.- acts as an important proliferative signal 
during tumorigenesis (Irani K et al, 1997). A role for heterotrimeric G protein 
subunits and low molecular weight GTPases in the stimulation of NHE-1 activity was 
first shown in 1996 when Hooley et al demonstrated that NHE-1 is a downstream 
effector of the Rho family of GTPase (Hooley R et al, 1996). However, activation of 
NHE-1 activity through these signaling pathways was mainly attributed to direct 
activation of kinases that induce NHE-1 phosphorylation, and Rac1- mediated 
activation of NHE-1 was shown to involve a MEKK1-dependent mechanism. 
However, in the light of our findings, in addition to the induction of a 
phosphorylation-dependent activation of NHE-1, Rac1 could also mediate increase in 
NHE-1 expression through transcriptional up regulation of its gene. Activation of 
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Rac1, in addition to triggering intracellular production of O2.-, has also been shown to 
regulate actin polymerization and Jun kinase (JNK) activation (Campbell SL et al, 
1998). In order to assess that Rac1-mediated induction of NHE-1 gene promoter 
activity was a function of an increase in intracellular O2.-, loss-of-function mutants of 
Rac1 containing specific amino acid substitutions in the activated RacV12 
background (Pervaiz S et al, 2001) were used. The RacV12L37 mutant activates JNK 
but is defective in inducing actin polymerization, whereas the RacV12H40 mutant 
induces actin polymerization but is defective in JNK activation. However, both of 
these mutations still retain the ability to generate intracellular O2.- (Joneson T and Bar-
Sagi D, 1998). In contrast, the RacV12H103 and RacV12K166 are deficient in O2.- 
production (Toporik A et al, 1998). Using Rac loss-of-function mutants it became 
clear that JNK activation and actin polymerization function of Rac was not involved 
in the survival advantage, and it was the O2.- producing function of Rac. NIH3T3 cells 
over expressing pIRES-RacV12, pIRES-RacV12H40 or pIRES-RacV12L37 were 
more resistant to cell death as compared to cells transfected with pIRES control vector 
or the Rac mutants deficient in O2.- production ( pIRES-RacV12H103A and pIRES-
RacV12K166E). In the light of our findings, it is plausible that in addition to a 
phosphorylation-dependent activation of NHE-1, O2.--dependent transcription of the 
NHE-1 gene may be a critical regulator of cell survival.  
Transient transfection with dominant negative form of Rac1, RacN17, showed that 
serum-induced activation of NHE-1 might involve Rac1.These results could have 
important relevance in tumor cells whereby an activated Rac1 could lead to increased 
O2.- levels and up regulation of NHE1 protein expression. 
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IV.11. H2O2 inhibits NHE-1 promoter activity and leads to increased 
susceptibility to cell death 
Intracellular concentration of O2.- is tightly regulated in mammalian cells by the 
superoxide dismutase (SOD) enzymes, i.e. the Cu/Zn superoxide dismutase 
(Cu/ZnSOD) in the cytoplasm and MnSOD in the mitochondria, which dismutate O2.- 
into H2O2 that is subsequently transformed into H2O and O2 by catalase or GSH 
peroxidases. As it is known that redox regulated transcription factors such as NFkB 
and AP-1 could be activated by H2O2 (Baeuerle PA and Baltimore D, 1996; Bowie A 
and O'Neill LA, 2000), we asked whether the increase in NHE-1 promoter activity in 
our system was indeed due to O2.- or a function of its dismutated product, H2O2. 
Our results show clearly that non toxic concentration of H2O2 was unable to activate 
the NHE-1 promoter. Instead, incubation of NIH3T3 1A8 cells with increasing 
concentration of H2O2 resulted in inhibition of NHE-1 promoter activity. These results 
indicate that O2.-, and not H2O2 is the reactive oxygen species responsible for the 
regulation of NHE-1 gene expression. Moreover, the use of two different reporter 
gene systems rules out the possibility that the observed inhibitory effect on NHE-1 
promoter activity could have been attributed to the inhibitory effect of H2O2 on the 
reporter gene (luciferase or CAT) itself. However, the inhibition of the NHE-1 
promoter activity by H2O2 could either be due to direct inhibition of H2O2 on NHE-1 
specific transcription factors or via an indirect effect on the level of O2.-. In this 
regard, it has been previously shown that production of H2O2 could induce a decrease 
in intracellular O2.- level by over-activation of the nuclear protein poly (ADP)-ribose 
polymerase (Clement MV et al, 1998). Hence, inhibition of the NHE-1 promoter 
activity could be a consequence of a decrease in intracellular O2.- concentration. In 
addition, results showing that inhibition of Cu/Zn SOD with DDC resulted in a 
 112
significant activation of the promoter also favor O2.- rather than H2O2 in the activation 
of the NHE-1 gene transcription. It should be pointed out that a previous report had 
demonstrated that H2O2 was an inducer of NHE-1 gene transcription in rat 
cardiomyocytes (Gan XT et al, 1999). This observed conflict could be due to 
involvement of different redox-regulated transcription factors in myocytes compared 
to cells used in this study. 
Moreover, similar to the result obtained by silencing NHE-1, pre-incubation of 
NIH3T3 cells with H2O2 sensitized NIH3T3 cells to etoposide-induced cell death. 
Taken together, these data provide strong evidence to support that the expression of 
NHE-1 is redox regulated, with opposing effects of O2.- and H2O2 on its promoter 
activity and protein expression.  
 
IV.12. Regulation of intracellular pH as one of the mechanisms of NHE-1-
mediated cell survival 
Activation of NHE-1 activity has been mainly attributed to direct activation of kinases 
leading to NHE-1 phosphorylation. In the light of present study, it wouldn’t be wrong 
to speculate a scenario in tumor cells where a persistent increase in intracellular O2.- 
would lead to a higher basal expression of NHE-1 protein. Hence, in tumor cells this 
persistent increase could lead to a more alkaline “set point” of the NHE-1 exchanger 
due to increased transcription of the NHE-1 gene. This hypothesis is supported by the 
results in M14 and U87 cells. Upon silencing of NHE-1 gene it was observed that 
steady state pHi dropped significantly. This is in contrary to experiments where 
NIH3T3 cells were used and little or no difference was observed between control and 
NHE-1 silenced cells. In addition, when NHE-1 protein was over-expressed in 
NIH3T3 cells, still no significant change was seen in pHi. Hence it can be concluded 
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here that over-expression of a quiescent H+ pump is not expected to significantly alter 
steady state pHi in normal cells. On the other hand, tumor cells seem to behave in a 
different manner. Expression of an activated form of Rac1 in M14 tumor cells seems 
to be responsible for the increase in NHE-1 protein level leading to a significant 
alkanization of the cytosol, while silencing NHE-1 expression had the opposite effect 
(acidification). Hence, a sustained increase in intracellular O2.- by activation of the 
small GTPase Rac could lead to a more alkaline “set point” of the NHE-1 exchanger 
due to increased transcription of the NHE-1 gene. Increase in the “set point” of the 
antiporter was described previously during HL60 cells differentiation (Rao GN et al, 
1993); differentiation of HL60 cells was accompanied by an increase in the cells’ 
basal pHi from 7.15 to 7.26. However, this increase in pHi could not be attributed to 
phosphorylation of the exchanger. In addition, constitutive expression of RacV12 in 
M14 cells also correlated with resistance to apoptotic cell death (Pervaiz S et al, 
2001). Hence, it is tempting to speculate that O2.--mediated activation of the NHE-1 
promoter activity could couple intracellular alkalinization with cell survival induced 
by activation of the small GTPase Rac1. Altogether, these findings could have 
tremendous implications in enhancing our understanding of the role of NHE-1 in 
tumorigenesis. It must be pointed out at this stage that although in tumor cells (U87 
and M14) a better pHi difference was observed when NHE-1 protein expression was 
altered; it merits further investigation in order to elucidate the exact role of pHi in 
tumorigenesis.Moreover recent evidence strongly suggests that, in addition to 
regulating pHi NHE-1 could be a critical regulator of cell sensitivity to apoptotic 
stimuli (Wu KL et al, 2003). Therefore, we hypothesized that the functional 
consequence of the redox regulation of NHE-1 protein expression could be linked to 
the regulation of cell sensitivity to death triggers. Regulation of pHi might be one of 
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the mechanisms downstream of NHE-1 that contributes to cell death resistance. Other 
possible mechanisms downstream of NHE-1 could be activation of survival pathways 
including PI3k/Akt pathway (Wu KL et al, 2004). As a lot of functions have been 
recently attributed to NHE-1 protein, it wouldn’t be wrong to speculate that pHi-
modulating function of NHE-1 may or may not be directly involved in its ability to 
induce survival in tumor cells. 
 
IV.13. Region of NHE-1 promoter involved in O2.--mediated activation 
NHE-1 gene is a large gene comprising of approximately 70 kilobases and can be 
regulated by a variety of stimuli. There is strong homology (>90%) between human 
and mouse NHE-1. As it became clear that O2.- acts as a signal for NHE-1 expression, 
and this increased expression of NHE-1 protein might play an important role in tumor 
cells, our next question was that where does O2.- act on the NHE-1 promoter and what 
are the candidate transcription factors. We used L6 rat muscle cells stably transfected 
with truncated versions of NHE-1 promoter. As was demonstrated by Besson et al. 
that 1.1 kb is the minimum length of promoter needed for maximum activity (Besson 
P et al, 1998), we used L6 cells stably transfected either with 1.1 kb, 0.9 kb, 0.5 kb, 
0.18 kb or AP2+ constructs. The AP2+ construct is 147 base pairs in length and it 
retains the AP2 binding site. Using either paraquat as a trigger for intracellular O2- or 
RacV12 expression, we demonstrate that O2.- seems to act somewhere between the 0.5 
to 0.2 kb proximal fragment of mouse NHE-1 promoter.  The region between 0.5 kb 
to 0.2 kb of mouse promoter correlates to an area of human NHE-1 promoter 
designated as area D. Evidence indicates that a number of regions of NHE-1 promoter 
contribute to the basal expression of the gene (Kolyada AY et al, 1998). In addition, 
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DNA footprinting experiments have revealed that different regions bind proteins of 
nuclear extract (Dyck JRB and Fliegel L, 1995). 
AP-1 was the first transcription factor identified to induce NHE-1 gene transcription. 
AP-2 transcription factor has been shown to be a key player (Dyck JRB and Fliegel L, 
1995; Rieder CV and Fliegel L, 2003). The chicken ovalbumin upstream promoter-
transcription factors (COUP-TFs) are orphan receptors involved in regulation of 
embryonic development and neuronal cell fate determination. Fernandez-Rachubinski 
et al. have shown that a nuclear hormone responsive element located at -841/-800 nt 
of the mouse NHE-1 promoter binds COUP-TF with enhancer activity (Fernandez-
Rachubinski F et al., 2001). Thyriod hormone and thyroid hormone receptor alpha 1 
(TRα1) has also been shown to regulate NHE-1 gene expression (Li X et al, 2002). 
Thus, it becomes clear that many transcription factors can influence NHE-1 promoter. 
Keeping in view the importance of NHE-1 in cell growth and differentiation, there 
might be many more elements affecting its expression. Much needs to be done to 
identify the candidate transcription factor(s) downstream of O2.- production in the cell. 
Identification and characterization of this element will provide us with a better 
understanding of redox-mediated regulation of NHE-1 gene. 
 
IV.14. Conclusions 
In summary, the results presented here provide strong evidence to implicate 
intracellular redox status in the regulation of NHE-1 promoter activity and gene 
expression. This report demonstrates that NHE-1 is a redox-regulated gene, and the 
effect of O2.- on NHE-1 gene transcription was demonstrated (a) by inhibiting O2.- 
production using DPI, a widely used inhibitor of O2.--producing oxidase, (b) by 

















































and (c) by showing that activation of NHE-1 promoter activity by the small GTPase 
Rac1, a widely accepted essential component for oxidase-mediated production of 
intracellular O2.-.Moreover, we show that level of NHE-1 protein expression can 
influence cell sensitivity to death triggers. An increase in NHE-1 protein expression 
downstream of O2.- production was able to bestow a survival advantage to the cell in 
response to apoptotic triggers, and vice versa. Interestingly H2O2 caused repression of 
the NHE-1 promoter and reversal of resistant phenotype. These observations are 
summarized in Figure 38. These findings could provide a mechanism for the 
regulation of cell survival by ROS, particularly in tumor cells, and may be important 
in enhancing our understanding of the relationship between cell redox status and 
tumorigenesis. However, apart from the possible oxidation mediated inhibition of key 
enzymes involved in tumor cells’ death, the exact mechanism involved in O2--
mediated cell survival is not yet well understood. Data presented here support that 
NHE-1 could be one such target. Indeed, in absence of NHE-1 gene expression DDC 
was unable to inhibit staurosporine-induced cell death in NIH3T3 cells despite 
inducing an increase in intracellular level of O2-. 
NHE-1-mediated inhibition of cell death has mostly been attributed to its ability to 
extrude H+ upon death triggers, and thereby create an intracellular environment non-
permissive for death execution. Recent evidence has pointed out towards many other 
important functions of NHE-1 protein in addition to its primary function of pHi 
modulation. Two recent reports have demonstrated that activation of NHE-1 induced 
pro-survival kinase PKB/AKT in human renal proximal tubule epithelial cells (Wu 
KL et al, 2004) and ERK activity in rat aortic vascular smooth muscle cells (Mukhin 
et al., 2004). In the light of these findings and our data presented here, we propose 
that redox regulation of NHE-1 expression could indirectly influence activation of 
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two well-known survival pathways, i.e. the PI3K/AKT and ERK. These extremely 
interesting findings point towards a multi-faceted role NHE-1 might play in a cell, 
rather then simply being a pHi-regulator. Thus, it wouldn’t be wrong to speculate that 
the NHE-1 mediated cell survival could or could not be dependent upon its primary 
function of pHi modulation. It has also been shown that paclitaxel induces apoptosis 
in breast cancer cells via protein kinase A and p38 MAPK-dependant repression of 
NHE-1 (Reshkin SJ et al, 2003). In light of these recent findings, the present report 
could have tremendous implications in our understanding of redox regulated 
sensitivity of cells to death triggers and may uncover the molecular mechanism 
involved in redox-mediated survival in normal and tumor cells. 
 
IV.15. Prospective studies 
In the light of current findings, it is pausable to plan for further studies in this 
important area of cancer research. It would be interesting to find out the region of 
NHE-1 promoter responsive to the superoxide signal, as it can help to discover the 
trancription factor(s) involved. Insight into the mechanism of increased cell survival 
upon increased expression of NHE-1 protein could shed light on the vital role this 
exchanger might play in tumor cell resistance to apoptotic signals. The cell survival 
ability of NHE-1 could be independent of its pHi modulation function, and this area is 
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